Introduction {#s1}
============

While the hard-wiring of circuits through chemical and electrical synapses provides the anatomic basis for behaviors, their outputs are subjected to modulation and reconfiguration by neuromodulators such as biogenic amines and neuropeptides (reviewed in [@bib53]; [@bib66]; [@bib92]). Unlike classical neurotransmitters that activate receptors at the vicinity of their release sites (active zones) to trigger rapid and short-lived responses, neuromodulators, released by the dense core vesicles (DCVs) either peri-synaptically or volumetrically, may diffuse over long distances and posses longer half-lives (reviewed in [@bib71]). Consequently, they can evoke long-range and prolonged responses through metabotropic G-protein-coupled receptors.

Neuroendocrine cells and neuromodulators have been examined in various animal models ([@bib39]; [@bib65]; [@bib97]). Neuromodulation exerts profound and lasting effects on physiology and behaviors across phyla. In many invertebrates, neuromodulators may be co-released with classic neurotransmitters at the presynaptic termini to exert local effects on circuits, or, they may be secreted from specialized peptidergic neurons that are devoid of active zones to exert long-range or global effects on neural networks ([@bib71]). Importantly, studies in invertebrate models made key contributions to the principle that neurons and their connections can be modified by a vast network of neuromodulators, enabling hard-wired circuits to generate flexible activity patterns underlying different states and adaptive behaviors.

Various neuromodulators that act on invertebrate circuits to affect movement, aggregation, sleep, arousal, and learning behaviors have been reported ([@bib30]; [@bib65]; [@bib92]). One of the best-described examples is the crustacean stomatogastric ganglion (STG), a single rhythm generating circuit that drives different motor patterns of the gut to either grind or filter food ([@bib38]). A variety of amines and neuropeptides, secreted from the descending and ascending peptidergic neurons directly on the STG neuropils, and likely also from the hemolymph, act on every neuron and synapse in this circuit, reconfiguring the network to produce different output patterns ([@bib12]; [@bib65]). Similarly, in the feeding circuit of the sea slug *Aplysia*, the balance between the activity of two interneurons, which determines whether food is ingested or egested, is regulated by neuropeptides ([@bib50]; [@bib92]). In *Drosophila* larvae, local modulatory neurons in the ventral nerve cord secrete biogenic amines to activate and modify crawling patterns ([@bib86]). In vertebrates, the hypothalamus produces and releases many hormones to control appetite, reproduction, circadian rhythms, and social behaviors ([@bib34]; [@bib85]; [@bib86]; [@bib89]). Similarly, the vertebrate spinal cord locomotory circuits are activated and modified by multiple amines that are secreted by descending neurons at the brainstem, as well as by secretory neurons that reside locally in lower vertebrates such as the lamprey (reviewed in [@bib68]).

Recent genomic analyses hinted the evolutionary origin of peptidergic signaling to be the last common bilaterian ancestor ([@bib69]). Evidence for cross-species functional conservation of certain neuromodulators is also emerging. Indeed, serotonin and dopamine signaling have been known to modify vertebrate and invertebrate motor function alike. Pigment Dispersing Factor (PDF), a neuropeptide that couples the motor rhythm with the circadian clock in *Drosophila* ([@bib78]), also couples the motor rhythm with the developmental clock, cyclic molting, in *C. elegans* ([@bib18]; [@bib60]; [@bib77]). Oxytocin and vasopressin peptides exert strong effects on sexually dimorphic behaviors ([@bib9]), as well as cognition in both mammals and the nematode *C. elegans* ([@bib8]; [@bib33]). A better understanding of neurosecretory cell development and function across the animal phyla is required to reveal the origin and principles that underlie neural network architecture and operation.

*C. elegans* allows for a genetic dissection of the roles of neuromodulators on behaviors ([@bib30]; [@bib41]; [@bib57]). In addition to biogenic amine neuromodulators, its genome contains 113 genes that may encode up to 250 distinct peptides of three classes ([@bib60]): the insulin-like (INS) ([@bib74]), FMRF-amide-related (FLP), and non-insulin/non-FMRF-amide-related (NLP) ([@bib45]). A number of these neuropeptides already have assigned roles, affecting 'simple' (locomotion, feeding, egg-laying) to 'complex' (mating, lethargus, aggregation, learning) behaviors ([@bib8]; [@bib10]; [@bib11]; [@bib15]; [@bib16]; [@bib22]; [@bib33]; [@bib44]; [@bib47]; [@bib62]; [@bib96]; [@bib99]; others). For instance, the NLP-type PDF-1 increases velocity and suppresses reversals through premotor and other interneurons ([@bib28]; [@bib67]). The insulin-like peptide INS-1 is secreted by an interneuron to alter salt taxis behavior upon starvation ([@bib93]). NPR-1, a receptor for the FLP-type FLP-18 and FLP-21, mediates context-dependent avoidance and aggregation behavior ([@bib18]).

The presence and morphology of specialized neuroendocrine systems have been described in many invertebrates and vertebrates ([@bib39]; [@bib97]). In comparison, the morphology and identity of the *C. elegans* neuroendocrine system remains to be better described and clearly defined. [@bib1] reported the first candidate *C. elegans* secretory neuron (NSM) to contain both clear and dense core vesicles. [@bib104] described another neuron (BDU) to 'have striking, darkly staining vesicles'. Reporters for neuropeptide-encoding genes are found to exhibit expression across the nervous system. Many *C. elegans* modulators of known functions act through neurons that clearly participate in classical chemical synaptic transmission. These notions led to a speculation that all *C. elegans* neurons secrete neuromodulators ([@bib41]), which predicts distributed peptidergic signaling.

However, as noted in [@bib104], the *C. elegans* samples utilized in these classic anatomic studies were optimized for visualization of active zones, not vesicle or other intracellular organelle preservation. This made anatomic determination of neurons with specialized endocrine properties -- devoid of active zones in other systems -- challenging. We recently completed the serial electron microscope (EM) reconstruction of several *C. elegans* larvae (Witvliet et al. in preparation), fixed by tannic acid and high-pressure freezing that allows for better preservation of intracellular structures in physiological states ([@bib80]; [@bib102]). These and our other unpublished EM studies reveal two distinct sources for neuropeptides. First, all classical chemical synapses contain a small portion of DCVs, typically residing at the periphery of presynaptic termini. Second, a small cohort of dedicated secretory neurons can be distinguished by the prevalence of DCVs, which can be further divided into two subgroups. One, including NSM, BDU, and a few other neurons, exhibits mixed anatomic features that may equally support both secretory and synaptic transmission; the other exhibits predominantly secretory anatomic features. RID, a neuron currently of incomplete anatomic reconstruction ([@bib104]), and of unknown function, belongs to the second group. Here we describe its anatomy, development and function.

The survival of animals depends on their ability to generate appropriate motor responses to a dynamic environment. Like all other animals, *C. elegans* responds to cues from their surroundings by altering motor strategies. How a hard-wired sensorimotor circuit adjusts its output constitutes a central question for neuroscience. Through anatomic, developmental, and functional analyses, we discover that RID is a peptidergic neuron that modulates the *C. elegans* motor state to sustain forward movement, and it does so in part through secreting a FMRF-amide family neuropeptide FLP-14. Our findings lay the groundwork for further interrogation of mechanisms that underlie neuroendocrine development, evolution, and circuit modulation.

Results {#s2}
=======

RID exhibits the ultrastructural hallmarks of a specialized endocrine neuron {#s2-1}
----------------------------------------------------------------------------

We reconstructed the dorsal nerve cord (DNC), a fascicle consisting of multiple motor neuron processes that innervate the dorsal body wall muscles. We reconstructed the entire length of a first stage larva (L1), and fragments of multiple young adults, by serial transmission EM (sTEM) ([Figure 1A--C](#fig1){ref-type="fig"}; Appendix 1). In all samples, we observed a single process that adopts a stereotypic location in the DNC and exhibits the hallmark features of a specialized neuroendocrine cell. Based on the topology of the fully reconstructed neuron and other criteria (Appendix 1), we identified this process to be the axon of a neuron named RID. As described in [@bib104], the RID soma resides in the anterior dorsal head ganglion. It sends a ventral-projecting process that reaches the ventral ganglion, loops around to enter the dorsal ganglion, turns posteriorly to enter the DNC, and runs along the entire length of DNC to reach the tail (illustrated in [Figure 1A](#fig1){ref-type="fig"}).10.7554/eLife.19887.002Figure 1.RID is a peptidergic neuron.(**A**) Schematic of the RID neuron. (**B**) sTEM reconstruction of RID and motor neurons in a L1 animal. Top panel, Skeletal reconstruction of motor neurons and respective processes in dorsal nerve cord (DNC). Yellow, RID; Green, DD; Light blue, DA; Dark blue, DB. Bottom panel, Volumetric reconstruction of the L1 RID cell body and dorsal cord neurite showed periodic swellings along the RID neurite. (**C**) Volumetric reconstruction of a portion of the RID axon in a young adult. Bottom, The neurite of RID (yellow), DD (pink). Middle, higher magnification versions of the regions indicated by the dashed boxes i, ii and iii. Top, Representative EM cross-section images of RID and DD boutons in the adult DNC. In the volumetric reconstruction, green spheres indicate synaptic vesicles (SVs), blue spheres dense core vesicles (DCVs), red shading indicates active zones, and light blue shading indicates mitochondria. (**D**) Top panels, a cytoplasmic GFP reporter illustrates the RID axon, followed by reporters for the DCV membrane protein IDA-1 and the neuropeptide INS-22 along the RID axon. Bottom panel, INS-22::GFP accumulated at coelomocytes (dotted circle), indicating that it was secreted. Scale bar, 5 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.002](10.7554/eLife.19887.002)

Our L1 and adult DNC reconstruction revealed several unreported features for the RID axon and the DNC. The DNC innervates the dorsal body wall muscles through *en passant* neuromuscular junctions (NMJs) ([@bib104]). The RID process resides dorsally within the fascicle, nested between the epidermis and GABAergic (DD) motor neuron processes. It exhibits periodic changes in diameters, from \~40 nm to \~400 nm (in L1s), and \~40 nm to \~750 nm (in adults), creating regularly spaced varicosities at \~1.3 µm (L1) and \~2.5 µm (adult) intervals along its entire length ([Figure 1B,C](#fig1){ref-type="fig"}). These varicosities intercalate between NMJs. In adults, they typically reside immediately adjacent to NMJs made by the DD motor neurons ([Figure 1C](#fig1){ref-type="fig"}).

The morphological features of these varicosities are distinct from those of their neighboring NMJs ([Video 1](#media1){ref-type="other"}). In both L1s and adults, NMJs made by all classes of motor neurons contain a mixed vesicle population with a stereotypic structural organization: a large pool of clear, \<40 nm synaptic vesicles adjacent to an active zone (415.6 ± 83.2 per bouton, by adult DD), and a small pool of \~40--70 nm DCVs residing at the periphery (10.5 ± 2.4 per bouton, by adult DD) ([Figure 1C](#fig1){ref-type="fig"}). In contrast, varicosities along the RID axon contain almost exclusively \~40--100 nm DCVs (20.3 ± 7.8 per bouton, by adult RID axon), the vast majority (78 out of 87) devoid of active zones. A small fraction of varicosities (9 out of 87) contain an active zone-like electron density, but none have associated DCVs.Video 1.Thirty-two consecutive serial sections of a part of the dorsal nerve cord in an adult wild-type animal.The RID process is outlined in pink, and the DD axon is outlined in green.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.003](10.7554/eLife.19887.003)10.7554/eLife.19887.003

RID can load and release neuropeptides. Consistent with these EM observations, expression of the fluorescently labeled tyrosine phosphatase receptor IDA-1, a DCV marker ([@bib108]), in RID produced a pearling pattern along the DNC, consistent with periodic DCV accumulation at specific locations along its process ([Figure 1D](#fig1){ref-type="fig"}). The exogenous expression of INS-22::GFP, a *C. elegans* neuropeptide marker ([@bib87]) in RID resulted in a similar pearling pattern that co-localized with IDA-1::RFP ([Figure 1D](#fig1){ref-type="fig"}). INS-22::GFP signals also accumulated in coelomocytes ([Figure 1D](#fig1){ref-type="fig"}), the scavenger cells that endocytose secreted substances. Hence RID exhibits the anatomic features of an endocrine cell that predominantly secretes neuropeptides.

RID fails to differentiate in the absence of a Six/SO homeobox transcription factor UNC-39 {#s2-2}
------------------------------------------------------------------------------------------

To address the role of RID, we performed a visual screen for genetic mutations that disrupt RID development. Using a fluorescent reporter (*Pceh-10*-GFP) (generated based on ([@bib2]; [@bib91]) that is expressed by four neurons RID, AIY, CAN, ALA and one sheath cell, we isolated a mutant *hp701* that exhibits fully penetrant and specific loss of the marker expression in RID ([Figure 2A](#fig2){ref-type="fig"}). *hp701* harbors a C to T substitution that results in a recessive and causative missense P298L mutation in *unc-39* ([Figure 2B](#fig2){ref-type="fig"}; Materials and methods). A canonical loss-of-function *unc-39* allele *e257,* which harbors a R203Q missense mutation ([@bib106]), fully recapitulates the RID phenotype of the *hp701* allele ([Figure 2B](#fig2){ref-type="fig"}) and failed to complement it.10.7554/eLife.19887.004Figure 2.RID fails to differentiate in *unc-39* mutants.(**A**) In *unc-39* mutants, RID soma (circle) and axon could not be detected by the *Pceh-*10-GFP marker, while other *Pceh-10*-GFP cells are present. Scale bar, 10 μm. (**B**) A predicted protein structure of UNC-39 compared with its Drosophila homologue SO, denoted with allelic information of *hp701* and *e257* mutations. (**C**) *unc-39* expression in the nervous system was observed in embryos (top panel), newly hatched L1 larvae (middle panel), and young adults (lower two panels). Scale bar, 10 μm. (**D**) Lineage map of ABalappaa, the neuroblast that gives rise to RID (ABalappaapa) in embryos of wild-type animals and *unc-39* mutants. *unc-39* mutants exhibited a range of mitosis changes. (**E**) Skeletal sTEM reconstruction of a fragment of the DNC of a wild-type and *unc-39* mutant. The RID axon is absent from the *unc-39* DNC. Red, RID; Yellow, DD; Green, VD; Light blue, DA/AS; Dark blue, DB. (**F**) Representative images of the EM cross-section from the DNC of *unc-39* mutants. Numbers (1-3) denote their approximate locations in **E**. RID process is absent in all three sections. The identity of neurons, hypodermis and muscles are labeled accordingly. Scale bar, 500 nm.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.004](10.7554/eLife.19887.004)10.7554/eLife.19887.005Figure 2---figure supplement 1.The expression pattern of UNC-39::GFP and phenotypes of *unc-39* mutants.(**A**) During embryogenesis, *unc-39::GFP* is expressed in both RID (arrowhead) and the RID sister cell (arrow) (t1), before the latter dies as a result of apoptosis (t2). (**B**) Known RID cell fate markers, such as *kal-1* (top panel), *ser-2* (middle panel), and *mod-1* (bottom panel) are present in wild type animals (arrow), but not *unc-39* mutants *hp701* and *e257*. (**C**) During early embryogenesis, the RID lineage-specific apoptosis activator UNC-3 is expressed in RID and the RID sister cell, but not in *unc-39* mutants. (**D**) The absence of RID in *unc-39* mutants is not due to ectopic apoptosis. Bottom Left, A schematic of the RID cell lineage: the ABalappaa neuroblast undergoes two consecutive rounds of mitosis to give rise to RID. Both the sisters of the RID precursor and RID undergo apoptosis. Top Panel, Apoptotic mutants *ced-3* and *ced-4* possess two RID neurons resulting from failure to activate apoptosis in the RID sister (arrowheads). However, a majority of *unc-39; ced-3* and *unc-39; ced-4* mutants still do not possess RID. Bottom Right, Quantification of genetic interaction from top panel. N = 10 animals/genotype. For **B**, **C**, and **D**, the putative position of RID and/or RID sister cell in *unc-39* mutants is designated by a circle.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.005](10.7554/eLife.19887.005)

UNC-39 is a homeobox transcription factor of the Six/SO family. Six/SO is necessary for the development of the fruit fly eye ([@bib17]), the insect endocrine gland corpora cardiac ([@bib23]), and the vertebrate forebrains ([@bib58]). *C. elegans unc-39* mutants exhibit variable defects in post-embryonic mesodermal differentiation, soma or neurite migration, and expression of terminal fate markers in several neurons ([@bib64]; [@bib106]). As previously reported ([@bib106]), our *unc-39* reporters (Supplemental Methods) were expressed by muscles and multiple neurons during embryonic development and into the adulthood ([Figure 2C](#fig2){ref-type="fig"}). Notably, we observed robust expression of *unc-39* reporters in the embryonic RID precursor ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), embryonic RID ([Figure 2C](#fig2){ref-type="fig"}, top panel), and newly hatched L1 larvae ([Figure 2C](#fig2){ref-type="fig"}, middle panel). Post-embryonically, *unc-39* expression was selectively decreased in some neurons, including RID ([Figure 2C](#fig2){ref-type="fig"}, lower panels).

Our analyses revealed a complete and specific loss of RID terminal differentiation in both *unc-39* alleles. First, all known fate markers (*kal-1*, *ser-2, mod-1, unc-3)* for RID (and a few other neurons) ([@bib13]; [@bib95]; [@bib100]) exhibited a complete and specific loss of expression in RID in both *unc-39* alleles ([Figure 2---figure supplement 1B,C](#fig2s1){ref-type="fig"}). Second, our sTEM reconstruction of segments of the DNCs of three *unc-39* adults failed to reveal a process that morphologically resembles the RID axon ([Figure 2E](#fig2){ref-type="fig"}, RID axon denoted in red in wild-type), while all present processes were unambiguously traced back to a motor neuron class ([Figure 2E,F](#fig2){ref-type="fig"}; Appendix 1). Third, the lineage development that gives rise to RID exhibited fully penetrant mitosis and terminal differentiation defects in *unc-39* embryos. The ABalappaa neuroblast gives rise to RID after two rounds of mitosis, where during each round the sister cells of the RID precursor and RID activate apoptosis ([@bib90]); illustrated in [Figure 2D](#fig2){ref-type="fig"}). By simultaneous DIC and fluorescent tracing, we confirmed that in wild-type embryos, the progeny of ABalappaa followed stereotypic spatial and temporal patterns for mitosis and apoptosis, and its designated anterior granddaughter turned on the RID (*Pceh-10*) fate marker shortly after the second round of mitosis ([Figure 2D](#fig2){ref-type="fig"}). In *unc-39* embryos, ABalappaa exhibited a missed, accelerated, or delayed second mitosis; its progeny did not turn on or maintain the *Pceh-10* marker and/or execute apoptosis ([Figure 2D](#fig2){ref-type="fig"}). Blocking apoptosis in the RID lineage by removing either the lineage-specific ([@bib100]), or global ([@bib107]) apoptotic activators/executors UNC-3, CED-3 and CED-4 did not restore RID in *unc-39* mutants ([Figure 2---figure supplement 1C,D](#fig2s1){ref-type="fig"}), further supporting the notion that the loss of RID is due to failure in differentiation, not ectopic apoptosis.

The loss of RID in *unc-39* mutants exhibits striking lineage-specificity. The CAN, ALA, RMED and RIA neurons are lineage-related to RID by sharing progenitors that give rise to ABalappaa ([@bib90]). They are present in both *unc-39* alleles, with either no or mild and variable defects (e.g. soma position) in adults. RID differentiation thus may be particularly sensitive to the perturbation of UNC-39 activity.

RID synthesizes multiple neuropeptides, including FLP-14 and INS-17 {#s2-3}
-------------------------------------------------------------------

The morphology of RID suggests that it functions as a specialized peptidergic neuron. To identify neuropeptides that are expressed by RID, we performed mRNA sequencing on differentiated RID neurons isolated from *C. elegans* larvae. Due to the absence of a strong RID-specific promoter that is required for cell sorting, we devised a subtractive transcriptome strategy, taking advantage of the complete and specific loss of RID in *unc-39* larvae to detect RID-enriched transcripts.

Briefly, we FACS-sorted *Pceh-10-*GFP-positive (GFP+) cells from wild-type and *unc-39(hp701)* second stage larvae ([Figure 3A](#fig3){ref-type="fig"}; Appendix 1). We compared transcripts of wild-type and *unc-39* GFP+ cells against their respective unsorted whole cell populations (All Cells) ([Figure 3B](#fig3){ref-type="fig"}; Appendix 1) to obtain two enriched transcript datasets for GFP+ cells in wild-type animals (RID, ALA, AIY, CAN, and a sheath cell) and *unc-39* mutants (ALA, AIY, CAN, and a sheath cell). The non-overlapping transcripts thus represent candidates that are either differentially expressed in RID, or differentially regulated by UNC-39 ([Figure 3C](#fig3){ref-type="fig"}).10.7554/eLife.19887.006Figure 3.Subtractive transcriptome profiling reveals neuropeptides expressed by RID.(**A**) The experimental design and schematic of cell isolation protocol by flow cytometry. SSC, side scatter. (**B**) The workflow of data analysis. (**C**) A venn diagram representation of neuropeptide transcripts enriched in wild-type and *unc-39* datasets. (**D**) A transcriptional reporter of *Pflp-14* exhibits expression in RID cell body (circle), along the RID axon (arrowheads) and other neurons, including those in the mid-body (PDE, bottom left panel) and tail (PLN, bottom right panel). Scale bar, 10 μm. (**E**) A transcriptional reporter of *Pins-17* exhibits expression in RID (circle) and other unidentified neurons. Scale bar, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.006](10.7554/eLife.19887.006)

In total, we identified 574 enriched transcripts from wild-type animals, and 867 from *unc-39* mutants. 421 transcripts were similarly enriched in both datasets; 599 preferentially enriched in either one of two datasets. Among them, 446 were more enriched in *unc-39* mutant cells, which may represent genes repressed by UNC-39; 153 were more enriched in wild-type cells ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}; Appendix 1). The last category represents candidates that are either highly enriched in RID or activated by UNC-39.

For the purpose of this study, our follow-up analysis strictly focused on the peptide-encoding transcripts highly enriched in RID. Both wild-type and *unc-39* datasets ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}) revealed enrichment for a handful of secreted peptide- or protein-encoding transcripts ([Figure 3C](#fig3){ref-type="fig"}; [Table 1](#tbl1){ref-type="table"}; [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}). As a validation of our approach, transcripts that are similarly enriched in both datasets ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}, positive controls) encode peptides expressed by neurons present in both wild-type and *unc-39* larvae, e.g. *nlp-15* (AIY), *hen-1* (CAN, AIY) ([@bib46]; [@bib47]; [@bib72]; [@bib103]), and *pdf-1* (ALA; our observation). By contrast, *flp-14*, *ins-17,* and *nlp-34* showed more enrichment in the wild-type dataset, with *flp-14* and *ins-17* exhibiting the most significant difference and abundant expression, making them candidate genes highly-expressed in RID. Reassuringly, using transcriptional reporters ([Figure 3D,E](#fig3){ref-type="fig"}; Appendix 1), we confirmed that *flp-14* and *ins-17* are robustly expressed in RID and additional neurons. For *flp-14*, these neurons include ALA (weak and variable expression), PDE, and PLN (strong expression, [Figure 3D](#fig3){ref-type="fig"}). Based on their soma positions, other neurons that consistently express *flp-14* may be AIM, AIY, and AVK.10.7554/eLife.19887.007Table 1.Identification of significantly enriched neuropeptide transcripts in RID by subtractive transcriptome profiling.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.007](10.7554/eLife.19887.007)GeneTranscript counts (Mean±SD)Transcript counts (Mean±SD)Enrichment in GFP+ Cells (Fold change)P values for the enrichment (FDR-corrected; n \>= 3 replica)**ClassSequence ID (Gene Name)GFP+ cells (wt)All cells (wt)GFP+ cells**\
**(*unc-39 mutants*)All cells**\
**(*unc-39 mutants*)*wild-type**unc-39 mutants**wild-type**unc-39 mutants***Insulin-family\
peptideF56F3.6\
(*ins-17)*265.6 ± 37.834.4 ± 10.5101.7 ± 68.756.0 ± 17.87.71.82.37E-060.72FLP-family peptideY37D8A.15 (*flp-14)*19547.2 ± 586.82917.5 ± 368.08562.1 ± 6291.93427.3 ± 1069.26.72.57.55E-080.53NLP-family peptideB0213.17\
(*nlp-34)*67.0 ± 23.29.8 ± 6.537.8 ± 35.313.3 ± 6.56.82.80.010.67

RID activity increases during forward locomotion {#s2-4}
------------------------------------------------

To address the function of the RID neuron, we monitored its activity pattern in behaving animals by calcium imaging. A genetic calcium sensor GCaMP6, fused with RFP (mCherry), was expressed in RID to monitor relative neuronal activity change. Parameters for spontaneous locomotion (directionality and instantaneous velocity) and neuronal activity (GCaMP/RFP ratio) were simultaneously acquired as described ([@bib5]; [@bib54]; [@bib105]); Materials and methods).

RID maintained low activity during reversals, and increased its activity during forward movement ([Figure 4A,B](#fig4){ref-type="fig"}). Increased calcium activity was observed in both the RID soma ([Figure 4](#fig4){ref-type="fig"}) and axon ([Video 2](#media2){ref-type="other"}). No other *Pflp-14-*positive neurons exhibited obvious activity change that correlated with forward movement. During the transition from reversals to forward movement, we consistently observed an activity rise in RID, typically with a significant lag (\~10 s) in reaching its peak when compared to the velocity rise ([Figure 4A](#fig4){ref-type="fig"}). A decrease in RID activity was observed following the transition from forward movement to reversals ([Figure 4A,B](#fig4){ref-type="fig"}). There was significant correlation between the rate of velocity change (acceleration and deceleration, X-axis) and the change in RID activity (Ca^2+^ rise and decay, Y-axis), when animals transited between forward movement and reversals, respectively ([Figure 4C](#fig4){ref-type="fig"}; p\<0.006 for forward to reversal; p=0.0007 for reversal to forward movement).10.7554/eLife.19887.008Figure 4.RID activity increase correlates with forward movements.(**A**) Representative velocity (top) and corresponding RID calcium activity trace (bottom) from a freely moving animal. Normalized ratiometric signal changes (ΔF/F), as well as the raw fluorescence intensities of GCaMP and cherry are shown. ΔF/F was used to calculate changes in calcium activity for each animal. Changes in positions of fluorescent signals were used to calculate velocity and directionality. (**B**) RID activity as measured by GCaMP/cherry ratio change (± SEM) during transition periods. Left panel, RID activity increased when animals transition from backward to fast forward locomotion. Right panel, RID activity decreased when animals transition from forward to backward locomotion. For **A** and **B**, dotted longitudinal lines indicate transition periods from backward to forward locomotion and vice versa. (**C**) Cross-correlation analyses between the change in RID activity and the change in velocity. Positive and negative slopes (Y-axis) indicate increase (Ca rise) and decrease (Ca decay) in RID, respectively. Positive and negative values on the X-axis indicate changes in velocity from backward to forward locomotion (acceleration) and from forward to backward locomotion (deceleration), respectively. For **B** and **C**, N = 10 animals/genotype. In **C**, each dot represents a transitional event.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.008](10.7554/eLife.19887.008)Video 2.Changes in the RID calcium transients in moving animals.RID activity increased during a period of acceleration in a forward bout, or during transitions from reversal to fast forward locomotion. Left panel: RFP; Right panel: GCaMP6. Note that multiple neurons expressed GCaMP6::RFP, but only RID (soma and axon) exhibited signal increase that was correlated with increased forward locomotion.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.009](10.7554/eLife.19887.009)10.7554/eLife.19887.009

RID is required for sustained forward locomotion {#s2-5}
------------------------------------------------

The activation of RID during forward movements and the positive correlation between the rate of its activity change with that of velocity change during the forward and reversal transition suggest that RID positively modulates forward movement. To examine this possibility, we quantified the effect of anatomic removal of RID on spontaneous motor behaviors.

*C. elegans* executes forward movement that is periodically disrupted by pauses, reversals, and turns ([@bib35]; [@bib75]). Our spontaneous motor behavior analyses were performed when wild-type animals exhibit exploratory behaviors ([@bib32]; [@bib54]). We quantified the directionality (forward, reversal, pause), sustainability (duration and frequency of re-initiation of movement from pauses), and speed (instantaneous velocity). Under our assay conditions (Appendix 1), wild-type *C. elegans* exhibited a predominant preference for forward movement (\>95% of total time) over reversals and pauses (\<5% combined). RID-ablated animals drastically reduced the propensity for forward movement (\~60% of total time), and increased the propensity for reversals (\~20%) and pauses (\~20%) ([Figure 5A](#fig5){ref-type="fig"}). RID-ablated animals exhibited a significant reduction in the duration ([Figure 5A''](#fig5){ref-type="fig"}) and velocity ([Figure 5A'''](#fig5){ref-type="fig"}) of each forward run, with more frequent re-initiation of forward movement ([Figure 5A'](#fig5){ref-type="fig"}). They also increased reversal re-initiation frequency ([Figure 5A'](#fig5){ref-type="fig"}), without significantly altering reversal duration ([Figure 5A"](#fig5){ref-type="fig"}). Hence, upon RID ablation, sustained forward movement was replaced by more frequent, shorter and slower forward runs, more pauses, and more reversals.10.7554/eLife.19887.010Figure 5.RID and FLP-14 potentiate sustained, long forward movements.(**A-A"'**) Spontaneous motor behavioral output, the propensity of directional movement and the interruption of forward movement between wild-type control (mock-ablated *Pceh-10-*GFP *animals*), RID-ablated *Pceh-10-*GFP animals, wild-type (N2), *unc-39,* and *flp-14* mutants. RID-ablated, *unc-39,* and *flp-14* mutants showed decreased propensity for long forward runs, replacing it with more frequent reversals and pauses. (**A**) Total fractional time animals of each genotype spent in forward, reversal, or pauses. (**A'**) Frequency of re-initiation of forward runs and reversals. (**A''**) Duration of forward and reversal runs. (**A"'**) Velocity of forward and reversal runs. (**B-B"'**) Spontaneous motor behavioral output, the propensity of directional movement and the interruption of forward movement between wild-type (N2), *ins-17,* and *ins-17 flp-14* mutants. (**B**) Total fractional time animals of each genotype spent in forward, reversal, or pauses. (**B'**) Frequency of re-initiation of forward runs and reversals. (**B''**) Duration of forward and reversal runs. (**B'''**) Velocity of forward and reversal runs. *ins-17* mutants did not show significant changes in motor behavior, while *ins-17 flp-14* generally resembled *flp-14* in motor behavior. N = 10 animals/genotype. Error bars are ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.010](10.7554/eLife.19887.010)10.7554/eLife.19887.011Figure 5---figure supplement 1.Raw data for spontaneous motor behaviors of animals quantified in [Figure 5](#fig5){ref-type="fig"}.Plots of the body curvature (Y axis, anterior to posterior) over time (X axis) of individual animals of the following genotypes: *hpIs202* (*Pceh-10-GFP* RID marker) mock-ablated, *hpIs202* (*Pceh-10-GFP* RID marker) RID-ablated, wild-type (N2), *unc-39,* and *flp-14*. Each heat-map plot represents one animal. N = 8--10/genotype. These recordings were performed on the same day. They were recorded on the same plate, one animal at a time, alternating through animals of each genotype. Forward and reversal movements are viewed by the directionality of the curvature propagation; velocities are viewed by the speed of curvature propagation. White regions represent times when the program lost track of the animal, which typically happened when the animal's head and tail touched each other during turns. Compared to their respective controls, RID-ablated animals, *unc-39,* and *flp-14* mutants exhibited reduced propensity and continuity of forward movements. Forward velocity of RID-ablated and *unc-39* animals was reduced. All defects were less prominent in *flp-14* mutants.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.011](10.7554/eLife.19887.011)10.7554/eLife.19887.012Figure 5---figure supplement 2.Frequency distribution of forward and reversal velocities quantified in [Figure 5](#fig5){ref-type="fig"}.Percentage distribution of forward and reversal velocities of individual animals of the following genotypes: *hpIs202* (*Pceh-10-GFP* RID marker) mock-ablated, *hpIs202* (*Pceh-10-GFP* RID marker) RID-ablated, wild-type (N2), *unc-39, flp-14, ins-17,* and *ins-17 flp-14*. Negative values represent reversal velocity; positive values represent forward velocity; zero value represents pauses. Compared to their respective controls, RID-ablated and *unc-39* mutants exhibited reduced velocities, specifically during forward locomotion. *flp-14* and *ins-17 flp-14* mutants showed a tendency towards reduced velocities, while *ins-17* mutants were similar to wild-type (N2). N = 10 animals/genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.012](10.7554/eLife.19887.012)

*unc-39* mutants, harboring an anatomic loss of RID among other defects, exhibited motor characteristics strikingly reminiscent to the RID-ablated animals -- replacing long foraging with more frequent, shorter and slower forward runs, more pauses, and more reversals ([Figure 5A--A"'](#fig5){ref-type="fig"}; [Videos 3](#media3){ref-type="other"} and [4](#media4){ref-type="other"}). These behavioral results complement the RID calcium imaging results, implying not only an association, but also causality of RID activation for sustained foraging.Video 3.Representative video of a L4 stage wild-type (N2) animal on an NGM plate with a thin-layer of OP50 bacteria food. Head is at the top at the beginning of the video.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.013](10.7554/eLife.19887.013)10.7554/eLife.19887.013Video 4.Representative video of a L4 stage *unc-39(hp701)* animal on an NGM plate with a thin-layer of OP50 bacteria food. Head is at the bottom at the beginning of the video.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.014](10.7554/eLife.19887.014)10.7554/eLife.19887.014

*flp-14* mutants partially recapitulate the motor defects caused by RID removal {#s2-6}
-------------------------------------------------------------------------------

We next addressed whether the role of RID in sustaining forward runs requires neuropeptides. We first examined the motor behaviors of *flp-14* and *ins-17* null mutants. The *flp-14* locus encodes three identical copies of the KHEYLRF amide peptide. The *flp-14* deletion allele, which removes the entire coding region of the FLP-14 peptide, exhibited motor characteristics that resembled *unc-39* and RID-ablated mutants, but with reduced severity ([Figure 5A--A'''](#fig5){ref-type="fig"}). *ins-17* mutants, by contrast, exhibited motor behaviors indistinguishable from wild-type animals; *ins-17 flp-14* double mutants showed behavioral defects that mostly resembled *flp-14* ([Figure 5B--B'''](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

Like RID-ablated or *unc-39* animals, *flp-14* mutants replaced long foraging with shortened forward runs and more frequent pauses and reversals ([Figure 5A--A''](#fig5){ref-type="fig"}; [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}; [Video 5](#media5){ref-type="other"}). *flp-14* mutants exhibited a reduced severity in their defects: the reduction of mean duration of forward runs, and the increase of re-initiation frequency of forward and reversal movements were less prominent as the RID-ablated or *unc-39* mutant animals. The mean forward and reversal velocity, reduced in both RID ablated and *unc-39* mutant animals, did not exhibit a statistically significant change in *flp-14* mutants ([Figure 5A--A"'](#fig5){ref-type="fig"}; [Figure 5---figure supplements 1](#fig5s1){ref-type="fig"} and [2](#fig5s2){ref-type="fig"}). Expressing a single copy of the wild-type *flp-14* genomic fragment *Si(FLP-14)* in *flp-14* mutants led to an increase in the duration of the forward runs and a decrease of the re-initiation frequency for both forward and reversal movements ([Figure 6A--A"', B--B"'](#fig6){ref-type="fig"}; [Figure 6---figure supplements 1](#fig6s1){ref-type="fig"} and [2](#fig6s2){ref-type="fig"}). The rescue of these motor defects confirms the functional requirement of FLP-14 in sustaining forward locomotion.10.7554/eLife.19887.015Figure 6.FLP-14 potentiates forward movements through RID.(**A--A'''**) Spontaneous motor behavioral output between wild-type *Si(FLP-14)*, *flp-14, flp-14;Si (FLP-14),* and *flp-14;Si (FLP-14);unc-39* where RID was genetically ablated. We quantified the propensity of directional movement (**A**), the continuity of forward movements, by the re-initiation frequency of forward and backward movement (**A'**) and the duration of forward and backward movement (**A''**), as well as the mean velocity of forward and backward movement. (**B--B'''**) Spontaneous motor behavioral output between wild-type *Si(FLP-14)*, *flp-14, flp-14;Si (FLP-14),* and *flp-14;Si (FLP-14)* where RID was ablated by a laser beam. All animals were in the background of the RID marker transgene (*Pceh-10-GFP*) for this set of experiments. A single copy of FLP-14 reversed *flp-14* mutants' motor defects; this effect was abolished when RID was laser ablated. N = 10 animals/genotype. Error bars are ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.015](10.7554/eLife.19887.015)10.7554/eLife.19887.016Figure 6---figure supplement 1.Raw data for spontaneous motor behaviors of animals quantified in [Figure 6A](#fig6){ref-type="fig"}.Plots of the body curvature (Y axis, anterior to posterior) over time (X axis) of individual animals of the following genotypes: the single copy insertion of a fragment of the *flp-14* genomic fragment in N2 background *Si(FLP-14)*, *flp-14*, *flp-14;Si(FLP-14), flp-14;unc-39, flp-14;unc-39;Si(FLP-14).* Each heat-map plot represents one animal. N = 10 animals/genotype. These recordings were performed on the same day. They were recorded on the same plate, one animal at a time, alternating through animals of each genotype. Forward and reversal movements are viewed by the directionality of the curvature propagation; velocities are viewed by the speed of curvature propagation. White regions represent times when the program lost track of the animal, which typically happened when the animal's head and tail touched each other during turns, or when the animal crawled to the edge of the plate. *Si(FLP-14)* restored *flp-14* mutants' defects and was similar to that of *Si(FLP-14). flp-14;unc-39;Si(FLP-14)* mutants exhibited severely reduced forward propensity, continuity, and velocity.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.016](10.7554/eLife.19887.016)10.7554/eLife.19887.017Figure 6---figure supplement 2.Raw data for spontaneous motor behaviors of animals quantified in [Figure 6B](#fig6){ref-type="fig"}.Plots of the body curvature (Y axis, anterior to posterior) overtime (X axis) of individual animals of the following genotypes: the single copy insertion of a fragment of the *flp-14* genomic fragment in the *hpIs202* (RID marker) background *Si(FLP-14), flp-14, flp-14;Si(FLP-14)*, and *flp-14;Si(FLP-14)* with RID ablated by a laser beam. The rescuing effect of *Si(FLP-14)* in *flp-14;Si(FLP-14)* was abolished upon RID ablation. All animals have *hpIs202,* a *Pceh-10-GFP* RID marker that facilitates RID ablation. N = 10 animals/genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.017](10.7554/eLife.19887.017)Video 5.Representative video of a L4 stage *flp-14(gk1055)* animal on an NGM plate with a thin-layer of OP50 bacteria food. Head is at the bottom at the beginning of the video.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.018](10.7554/eLife.19887.018)10.7554/eLife.19887.018

To determine if FLP-14 from RID contributes to its requirement for sustained forward movement, we removed RID either genetically using the *unc-39* mutation ([Figure 6A](#fig6){ref-type="fig"}; [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), or by laser ablation ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}) in *flp-14* animals carrying the rescuing transgene *Si(FLP-14).* Both manipulations led to reduced duration and velocity in forward runs, and increased bout initiation frequency ([Figure 6](#fig6){ref-type="fig"}; [Figure 6---figure supplements 1](#fig6s1){ref-type="fig"} and [2](#fig6s2){ref-type="fig"}). Together, these results suggest that FLP-14 promotes forward movement, and RID is the key cellular origin for such a role. The less severe defects of *flp-14* mutants also implicate the presence of additional effectors through which RID promotes forward runs.

RID stimulation promotes forward movement, through FLP-14 and other effectors {#s2-7}
-----------------------------------------------------------------------------

We further examined whether the role of RID in sustaining the forward motor state involves FLP-14 by examining the effect of optogenetic activation of RID. Through repurposing an endogenous *C. elegans* embryonic ubiquitin-ligase system ([@bib6]), we restricted the expression of Chrimson, a light-activated cation channel ([@bib56]) to RID ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}; Appendix 1). Briefly, we tagged Chrimson with ZF1, a degron recognized by an embryonic-specific E3 ligase ZIF-1, so that selective chrimson degradation in non-RID neurons could be induced by an exogenous expression of ZIF-1 (Details described in Appendix 1). Due to potential concerns on a delay or ineffectiveness in optogenetic stimulation of DCV exocytosis ([@bib7]), we used a robust stimulation protocol (a three-minute light ON/three minute light OFF cycle; Materials and methods; Appendix 1), where we compared the run length with or without stimulation ([Figure 7A](#fig7){ref-type="fig"}), as well as the change of mean velocity before and after stimulation during a forward run ([Figure 7B,C](#fig7){ref-type="fig"}).10.7554/eLife.19887.019Figure 7.Activation of RID promotes forward movements in part through FLP-14.(**A**) The distribution of the mean run length for all light ON (RID stimulation) and light OFF (no RID stimulation) periods. (**B--C**) A comparison of the motor behavior response before and after RID optogenetic stimulation in wild-type, *unc-39,* and *flp-14* animals. The change of speed (phasic velocity) before and after RID stimulation in wild-type, *unc-39* and *flp-14* animals, respectively, was quantified in **C**. In response to RID stimulation, wild-type animals showed increased velocity and run length during a forward run. This response was abolished in *unc-39* mutants and reduced in *flp-14* mutants. N = 6--26 animals/per genotype.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.019](10.7554/eLife.19887.019)10.7554/eLife.19887.020Figure 7---figure supplement 1.Restricting chrimson expression in RID by repurposing an embryonic E3 ligase.(**A**) Top panel, Representative image of an integrated transgenic array with restricted expression of Chrimson::GFP::ZF1 in the RID and CAN neurons. Most animals in the transgenic strain exhibited expression of Chrimson in RID and CAN. Bottom panel, When Chrimson::GFP in the CAN neuron was targeted for degradation using an endogenous *C. elegans* embryonic ubiquitin-ligase system, 10% of the population had Chrimson expression restricted to the RID neuron. Scale bar, 20 μm. The bottom panel is a representative image of transgenic animals used for optogenetic experiments. (**B**) Raw speed (phasic velocity) traces of individual wild-type, *flp-14*, *unc-39,* and *npr-4 npr-11* before (lights off) and after RID stimulation (lights on).**DOI:** [http://dx.doi.org/10.7554/eLife.19887.020](10.7554/eLife.19887.020)

Wild-type animals exhibited longer forward runs during periods of stimulation ([Figure 7A](#fig7){ref-type="fig"}). This effect was abolished in both *flp-14* and *unc-39* mutant animals ([Figure 7B,C](#fig7){ref-type="fig"}). Moreover, when wild-type animals were executing forward movement, stimulation of RID induced a velocity increase ([Figure 7B,C](#fig7){ref-type="fig"}; [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}; [Video 6](#media6){ref-type="other"}). This effect was reduced and abolished in *flp-14* and *unc-39* mutants, respectively ([Figure 7B,C](#fig7){ref-type="fig"}; [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}).Video 6.Representative video of a young adult ZM9315 (RID-specific Chrimson) animal on a thin NGM plate without food, upon RID optogenetic stimulation while the animal was executing forward movement. Head is labeled by the circle on the top right at the beginning of the video.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.021](10.7554/eLife.19887.021)10.7554/eLife.19887.021

Consistent with the observation that RID activity rise and decay significantly lag behind the directional transition, the optogenetic stimulation of RID when animals were executing reversals did not lead to a prompt switch to foraging ([Video 7](#media7){ref-type="other"}). Taken together, all results consistently point to a modulatory, instead of a deterministic role of RID for the motor state: RID is dispensable for *C. elegans* to execute or transit between foraging and reversals, but its activation sustains longer forward runs, and such a role requires a neuropeptide FLP-14 and additional contribution from unidentified factors.Video 7.Representative video of a young adult ZM9315 (RID-specific Chrimson) animal on a thin NGM plate without food, upon RID optogenetic stimulation during reversals. Head is labelled by the circle at the left side at the beginning of the video.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.022](10.7554/eLife.19887.022)10.7554/eLife.19887.022

The loss of two predicted FLP-14 receptors, NPR-4 and NPR-11, does not recapitulate the effect of RID loss {#s2-8}
----------------------------------------------------------------------------------------------------------

Identifying the physiological receptors of FLP-14 is necessary for determining the downstream signaling of the RID neuron. NPR-11 and NPR-4, two GPCRs expressed by several interneurons ([@bib15]; [@bib19]) were the predicted candidate FLP-14 receptors ([@bib30]; [@bib41]). However *npr-4 npr-11* mutant animals exhibited no or very modest motor defects ([Figure 8A](#fig8){ref-type="fig"}). Optogenetic activation of RID in *npr-4 npr-11* double mutants yielded effects identical to wild-type animals ([Figure 8B--D](#fig8){ref-type="fig"}; [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). These results suggest that either the prediction for receptors is incorrect, or, because both NPR-4 and NPR-11 were predicted to bind multiple ligands, their effects on the forward run are obscured by the activity of other ligands and neurons.10.7554/eLife.19887.023Figure 8.FLP-14 may not function through predicted GPCR receptors.(**A--A'''**) Spontaneous motor output, the propensity of directional movement, and the interruption of forward movement between wild-type (N2) and *npr-4 npr-11* animals. Unlike the case for *flp-14* and *unc-39* mutants, or RID-ablated animals, *npr-4 npr-11* double mutants did not exhibit significant motor behavioral changes. N = 10 animals/per genotype. Error bars are ± SEM. (**B**) The distribution of the mean run length for all light ON (RID stimulation) and light OFF (no RID stimulation) periods. (**C, D**) A comparison of the motor behavior response before and after RID optogenetic stimulation in *npr-4 npr-11* mutants. The change of speed (phasic velocity) before and after RID stimulation in *npr-4 npr-11* animals was quantified in **D**. Wild-type and *npr-4 npr-11* double mutants showed a similar increase of run length and velocity in response to RID stimulation. (**E**) A schematic summary of our findings on RID's role in sustaining forward locomotion (upper panel), and a speculative model of its currently unknown circuit mechanism (lower panel).**DOI:** [http://dx.doi.org/10.7554/eLife.19887.023](10.7554/eLife.19887.023)10.7554/eLife.19887.024Figure 8---figure supplement 1.The loss of PVC or AVB alone does not abolish RID activity rise during forward movement.(**A**) Representative velocity (top) and corresponding RID calcium activity trace (bottom) from a freely moving animal with PVC (and other neurons) ablated. Normalized ratiometric (GCaMP/Cherry) signal changes (ΔF/F), as well as the raw fluorescence intensities of GCaMP and cherry are shown. ΔF/F was used to calculate changes in calcium activity for each animal. Changes in positions of fluorescent signals were used to calculate velocity and directionality. (**B**) RID activity in PVC (and other neurons)- ablated animals as measured by GCaMP/cherry ratio change (± SEM) during transition periods. Top panel, RID activity increased when animals transitioned from backward to fast forward locomotion. Bottom panel, RID activity decreased when animals transitioned from forward to backward locomotion. For **A** and **B**, dotted longitudinal lines indicate transition period from backward to forward locomotion and vice versa (**C, D**). The same analyses as in **A** and **B**, except that experiments were performed in animals where AVB (and other neurons) were ablated. (**E, F**) Cross-correlation analyses between the change in RID activity, and the change in velocity in PVC (and other neurons)- (**E**) and AVB (and other neurons)-ablated animals (**F**). Positive and negative slopes (Y-axis) indicate increase (Calcium Rise) and decrease (Calcium Decay) in RID activity, respectively. Positive and negative values on the X-axis indicate changes in velocity from backward to forward locomotion (acceleration) and from forward to backward locomotion (deceleration), respectively. For **B**, **D**, **E** and **F**, N = 9--10 animals/genotype. In **E** and **F**, each dot represents a transitional event.**DOI:** [http://dx.doi.org/10.7554/eLife.19887.024](10.7554/eLife.19887.024)

Discussion {#s3}
==========

Motor circuits must allow output flexibility for animals to select and adjust their motor strategies. Here we identify a previously unknown endocrine component of the *C. elegans* motor circuit, and reveal its role in promoting the forward state. The circuit mechanism that enables *C. elegans* to modulate the propensity of directionality incorporates a specialized peptidergic neuron.

Similar ultrastructure of invertebrate neuroendocrine cells {#s3-1}
-----------------------------------------------------------

The modulatory nature of neural networks is ubiquitous, and likely of ancient evolutionary origin ([@bib69]; [@bib83]). The EM samples used in this study allowed us to characterize the distribution of neuromodulatory cells in the *C. elegans* nervous system. Similar to the case of the crustacean STG ([@bib55]), and in the brain ([@bib63]), we observed a wide distribution of DCVs across most neuropils with different distribution patterns. Most neurons have sparse DCVs localized to the periphery of classic presynaptic termini. But some neurons, such as RID, are specialized endocrine cells that predominantly harbor DCV pools. A precise measurement of the DCV size in this dataset was difficult due to the section thickness (70 nm), but they are easily distinguishable from clear synaptic vesicles by size (\>40 nm) and dark appearance. Like synaptic vesicles, they cluster in bouton-like compartments that lack active zones, or, do not tether around them when active zone-like structures are present in the compartment. Hence, contents of DCVs may be co-released at synapses with neurotransmitters, as well as be released diffusely and asynchronously. The ultra-structural criteria for neuroendocrine cells in *C. elegans* are consistent with those in other systems.

Conservation of RID's peptidergic function among nematodes {#s3-2}
----------------------------------------------------------

*Ascaris suum*, a large parasitic nematode, encodes AF2, a KHEYLRF amide neuropeptide identical to the *C. elegans* FLP-14. By in situ hybridization and mass spectrometry, AF2 was found to be strongly expressed by *Ascaris suum*'s RID-equivalent neuron ([@bib49]), indicating a conservation of not only overall nervous system organization, but also the cellular and molecular properties between nematode species.

*C. elegans* RID promotes the forward motor state in part through secreting FLP-14. These results are complementary to the reports that a bath application of AF2 to the *Ascaris suum* neuromuscular preparation potentiated the depolarization of body wall muscles and the forward-driving cholinergic motor neurons ([@bib20]; [@bib73]; [@bib94]; [@bib98]). These results implicate that RID may also activate body wall muscles and/or forward-driving motor neurons to promote forward movement.

A multi-layered neuromodulation at motor circuits {#s3-3}
-------------------------------------------------

Descending interneurons that release neuromodulators to modify the activity pattern of motor circuits have been identified in flies, crustaceans, fish and rodents (reviewed in [@bib68]). Being the sole neuron that extends a process throughout the entire length of the dorsal nerve cord, RID resembles a descending peptidergic modulator of the motor circuit. We show that the loss of RID does not abolish the animal's ability to execute forward movement, but reduces its duration and velocity, whilst increasing the propensity for the opposing motor modes. RID exhibits an activity increase after animals switch from reversals to foraging, and a decrease when they transit to reversals. Optogenetic stimulation of RID prolonged forward runs, but was insufficient to cause an immediate switch from the reversal mode to foraging. Notably, RID was one of the neurons that exhibited a coordinated activity pattern with known components of the forward motor circuit in a pan-neuronal imaging study on immobilized animals ([@bib52]). All results are consistent with RID being a positive modulator for the forward-driving motor circuit.

Activity of the crustacean STG is influenced by nearly 20 neuromodulators, at each neuron and throughout its connectivity ([@bib65]). Similarly, the *C. elegans* motor output can be modulated at multiple layers, by different neuromodulators and from different neuronal origins. Some neuromodulators modify the activity of the core motor circuit components. An escape behavior is facilitated by tyramine released by an interneuron (RIM), which inhibits a premotor interneuron (AVB) to halt forward movement, and simultaneously activates the GABAergic motor neurons (VDs) to induce deep bending ([@bib26]; [@bib76]). Upon exposure to food, dopaminergic sensory neurons activate an NLP-12-releasing interneuron (DVA), which acts upon cholinergic motor neurons ([@bib43]) to reduce forward runs, retaining animals on food ([@bib11]). Other neuromodulators function through complex and not yet deciphered circuit pathways: PDF-1 promotes forward runs ([@bib47]) and roaming ([@bib28]). It is released by a forward-promoting premotor interneuron (AVB) and other neurons, and may act through multiple and upper layer interneurons ([@bib28]). A NLP-12-releasing interneuron (DVA) coordinates with a FLP-1-releasing interneuron (AVK) to facilitate a body posture change that is associated with halting the forward runs when animals encounter an oxygen reduction ([@bib44]). Our results add another layer to motor circuit modulation - a descending input to the motor circuit from a FLP-14-releasing neuron RID.

The circuit mechanism of RID remains unknown {#s3-4}
--------------------------------------------

The *C. elegans* core motor circuit components for executing forward locomotion have been well established: the premotor interneurons (AVB, PVC) provide electrical and chemical synaptic inputs, respectively, to potentiate a cholinergic motor neuron group (the B motor neurons), which innervate and organize muscle contractions in a sequential order to propel the animal forward (reviewed in [@bib109]). How this core circuit activity is regulated is less clear.

A full elucidation of the functional connectivity of RID awaits future investigation ([Figure 8E](#fig8){ref-type="fig"}), as our current exploration indicates complexity. Two main reported inputs to RID in the adult wiring diagram are the premotor interneurons of the forward motor circuit, PVC and AVB, ([@bib104]). Such a circuit disposition would allow RID to function downstream of the forward-driving premotor interneurons to promote forward bouts. Ablation of PVC and AVB separately (and with other interneurons); however, did not abolish the RID's activity rise during, or coordination with, forward movement ([Figure 8---figure supplement 1A,B,E](#fig8s1){ref-type="fig"}). They may act redundantly, or additional inputs may activate RID. A full EM reconstruction of RID in adults is required.

The *C. elegans* adult wiring diagram deduced GABAergic motor neurons and hypodermis as RID's postsynaptic partners, based on their apposition to a few active zones of the RID axon ([@bib104]). Because the majority of RID presynaptic termini do not contain active zones, the peptidergic nature of RID emphasizes the necessity to identify FLP-14 downstream signaling through its receptors, instead of strictly based on the active zone structures. The striking analogy between the anatomic structure and cellular contents of RID in different nematode species suggests that RID may directly activate body wall muscles and forward-driving motor neurons, and if so, they would involve unpredicted receptors. Screening for GPCR receptors that exhibit physical interactions with FLP-14 offers a plausible entry point.

Causes for the phenotypic difference between removing RID and FLP-14 {#s3-5}
--------------------------------------------------------------------

In our behavioral assays, RID-ablated animals bear close resemblance to the characteristics and severity of the motor defects exhibited by our *unc-39* mutants. *flp-14* mutants, on the other hand, exhibited phenotypes of the same characteristics but with visibly reduced severity. Such a difference indicates that either RID functions through both FLP-14 and additional effectors to promote forward runs (a possibility that is also consistent with the reduced, instead of abolished motor response upon RID optogenetic stimulation in *flp-14* mutants), and/or, FLP-14 released from additional neurons exert an opposing effect on the forward runs.

We have excluded the possibility of a major involvement of INS-17, the other abundantly expressed neuropeptide by RID, because *ins-17* mutants did not exhibit obvious motor defects. We also tested a possibility that defective GABA uptake may also contribute to the influence of RID on forward runs. RID expresses *snf-11*, a plasma membrane GABA transporter ([@bib70]), suggesting that RID could take up GABA, and either modulate motor output by removing GABA from the surroundings, or by re-releasing the acquired GABA. However, we found that *snf-11* mutants did not show changes in forward and reversal propensity and *snf-11; flp-14* double mutants exhibited the similar motor characteristics as *flp-14* single mutants. PDF-1, a neuropeptide with a known effect on forward runs, was suggested to be expressed by RID ([@bib48]). However, our examination of a PDF-1 reporter strain from a recent study ([@bib82]) showed that the *Ppdf-1*-positive neuron was instead ALA; a notion that also explained why in our datasets, *pdf-1* was an equally enriched transcript from both wild-type and *unc-39* animals ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). NLP-34 could be another RID effector despite its fairly low abundance and less significant enrichment ([Table 1](#tbl1){ref-type="table"}), but a lack of *nlp-34* mutants prevented us from examining its involvement. In summary, we have not been able to identify other effectors from available reagents.

These negative results would be consistent with another possibility: FLP-14 released from other neurons opposes the effects of FLP-14 released from RID. The release of the same neuropeptide from different neurons can elicit distinct actions on network activity due to different co-transmitters in different neurons, or spatial compartmentalization of the respective signals. Indeed, our *Pflp-14* reporter exhibited expression in several additional neurons, some of which have been implicated in promoting pauses (ALA) ([@bib31]) or inhibiting reversals (AIY) ([@bib35]). Moreover, we have found that simultaneous optogenetic stimulation of all *Pflp-14-*positive neurons induced immediate reversals, instead of promoting forward runs.

We propose that while RID secretes FLP-14 as a key effector in modulating motor circuit output, RID may also function through additional co-effectors, and FLP-14 may play opposing roles via different neurons. Because most *C. elegans* neurons likely co-express classical neurotransmitters and neuropeptides, and the latter may interact with multiple receptors, an incomplete phenotypic recapitulation upon the perturbation of neurons, neuropeptides that they produce, and receptors that they act upon, may not be uncommon.

A role for the Six family of transcription factors in mitosis and endocrine differentiation {#s3-6}
-------------------------------------------------------------------------------------------

The UNC-39/Six/SO family transcription factors regulate development in various animals and tissues, and human mutations in Six genes are associated with multiple disorders including cancer ([@bib29]), holoprosencephaly ([@bib79]), branchio-oto-renal syndrome ([@bib42]), and Human Myotonic Dystrophy Type 1 ([@bib37]). Our study pinpoints a critical, lineage-specific role of a Six family transcription factor in mitosis, a cellular function that may unify and underlie vastly diverse phenotypic presentations. In *C. elegans*, while multiple cells are affected by *unc-39* mutations, the RID lineage is particularly sensitive to the perturbation of UNC-39 activity. A key feature of the RID lineage defect was the random timing of the second round of mitosis in precursor cells. Such a phenotype implies a crucial role for UNC-39 in the onset of and exit from the cell cycle that is to be followed by RID terminal differentiation. Mechanisms that couple cell cycle and terminal differentiation have remained elusive ([@bib36]). We propose that UNC-39 and its RID lineage-specific partners may be responsible for such a coupling. The absence of corpora cardiac, the insect pituitary in *Drosophila SO* mutants further entices the speculation of functional conservation for the Six transcription factors in endocrine development ([@bib23]).

The molecular profiles of neurons of diverse lineages facilitate the exploration of the cellular properties that endow their synaptic connectivity and functional specificity, as well as their evolutionary origins. Animal models such as *C. elegans* and *Drosophila* have a rich repertoire of genetic tools including mutants with specific and known lineage changes ([@bib40]). Methods to collect sufficient quantities of fully differentiated neurons from intact *C. elegans* for mRNA sequencing have been developed ([@bib51]; [@bib88]; [@bib101]). By comparing the transcriptome profiles obtained from specific cells from wild-type animals and *unc-39* mutants, we have established a robust pipeline that led to the identification of both reported and previously unknown RID-enriched transcripts ([Supplementary files 1](#SD1-data){ref-type="supplementary-material"} and [2](#SD2-data){ref-type="supplementary-material"}). Some of these transcripts represent candidate transcripts either activated or repressed by UNC-39. A well-controlled subtractive transcriptome dataset should provide not only cell-type markers, but also targets that are regulated by lineage-specifying transcription factors. The functional validation of neuropeptides obtained from this dataset suggests its benefit and utility for other studies.

Materials and methods {#s4}
=====================

Strains and constructs {#s4-1}
----------------------

*C. elegans* were cultured on standard Nematode Growth Medium (NGM) plates seeded with OP50, and maintained at 22°C. *hp701* was isolated by EMS mutagenesis of a strain carrying an integrated *Pceh-10-GFP* array (*hpIs202*), identified through a combination of SNP mapping and whole genome sequencing ([@bib21]; [@bib25]), followed by rescuing by a *unc-39-*containing fosmid and a *unc-39* minimal genomic clone. *hp701* and other mutants obtained from the *Caenorhabditis* Genetics Center (CGC) were backcrossed at least 4x against N2 prior to usage. See Supplemental Methods for a complete list of mutants, transgenic lines, and constructs.

Electron microscopy {#s4-2}
-------------------

L1 (N2) or young adult animals (N2 and *hp701*) were packed into 3 mm diameter aluminum carriers and frozen using a Leica EM HP100 high-pressure freezer. Subsequent fixation and freeze substitution was performed as described ([@bib102]). Samples were infiltrated and embedded in the Spurr resin. 70 nm transverse serial sections were prepared and imaged using the FEI Techai 20 TEM at 200 kV (x29,000). For L1, the entire length of RID axon along the dorsal cord was reconstructed. For adults, 20--30 µm of the dorsal nerve cord was reconstructed. See Supplemental Information on EM reconstruction and analyses.

Embryonic lineage analysis {#s4-3}
--------------------------

Strains (*hpIs202* and *unc-39; hpIs202*) were cultured and recorded at 25°C. Embryos were mounted at 1--4 cell stages, and recorded every 35 s with 25 z-levels. After \~350 z-scans (200 min) with DIC optics, the GFP fluorescence optics was automatically activated and exposed for every 20th z-scan till 320 min of development, and then every 30th z-scan till the three-fold stage. Recording was performed at 630x on a 4D microscope controlled by *TimeToLive* (*Caenotec*-Prof. Ralf Schnabel [r.schnabel\@tu-bs.de](http://r.schnabel@tu-bs.de)). RID and neighboring lineage cells were traced using SIMI°Biocell (SIMI Reality Motion Systems GmbH, <http://www.simi.com/de/home.html>) until the late 1.5-fold stage (340 and 360 min) as described ([@bib84]).

Preparation of dissociated larval cells for cell sorting {#s4-4}
--------------------------------------------------------

Synchronized *hpIs202 (Pceh-10-GFP)* and *unc-39(hp701); hpIs202* larval stage 1 (L1) animals were grown on 150 mm 8P plates seeded with NA22 for approximately \~12 hr until they reached larval stage 2 (L2). Cells were extracted from L2s. See Supplemental Information for detailed methods.

Laser ablation {#s4-5}
--------------

Synchronized *hpIs202 (Pceh-10-GFP)* L1 animals were immobilized and RID ablated using the MicroPoint laser as described ([@bib27]). Mock-ablated animals were L1s of the same genotype processed similarly, except that they were not exposed to the laser. L4 RID- and mock-ablated animals were confirmed for the status of RID prior to locomotion analyses.

Locomotion assay {#s4-6}
----------------

Automated tracking and locomotion analyses were performed as described ([@bib32]). Detailed description of experimental conditions is provided in the Supplemental Information.

Calcium imaging {#s4-7}
---------------

The third stage (L3) *hpIs587 (Pflp-14-GCaMP6::cherry)* animals were placed on a drop of M9 buffer on top of a 2.5% agar pad, covered with a cover slip. Four \~1 mm × 1 mm 0.001 inch-thick polycarbonate pieces (Catalog \# 9513K12, McMaster-Carr) between the agar pad and coverslip served as spacers to allow movement. Each recording lasted for 3 min. Images were captured using a 20x objective on a Zeiss Axioskop 2 Plus equipped with an ASI MS-40000 motorized stage, a dual-view beam splitter (Photometrics) and a CCD camera (Hamamatsu Orca-R2). The 4x-binned images were obtained at 10 frames per second. See Supplemental Information for detailed methods.

Optogenetic stimulation {#s4-8}
-----------------------

We restricted the expression of a codon-optimized version of Chrimson to the RID neuron, and stimulated wild-type, *flp-14(gk1055), unc-39(hp701)* and *npr-4(tm1782)npr-11*(*ok594*) animals carrying the same transgene using a Diode red laser while animal locomotion was tracked under dark-field imaging by infrared light. The stimulation and tracking were performed using the Colbert (COntrol Locomotion and BEhavior in Real Time) system ([@bib59]). The locomotion was recorded for each animals, and their trajectories were then extracted and analyzed as described analyzed as previously described ([@bib61]). See Supplemental Information for detailed methods.

Electron microscopy analysis {#s4-9}
----------------------------

Images were stitched and aligned using TrakEM2 ([@bib14]). In the L1 animal, all neurons were identified based on cell body position ([@bib90]), synapse pattern and neurite trajectory ([@bib104]). In the adult EM reconstruction, all neurons were identified by characteristic synapse patterns and trajectories ([@bib104]). Volumetric reconstruction of neurons was performed using TrakEM2 and skeleton tracing using CATMAID ([@bib81]) followed by rendering in Blender (<http://www.blender.org>).

Fluorescence microscopy and confocal imaging {#s4-10}
--------------------------------------------

For imaging dense core vesicle (*Pceh-10-IDA-1::cherry)* and neuropeptide fluorescent markers (*Pceh-10-INS-22::GFP)*, expression patterns of UNC-39 (*Punc-39-GFP, Punc-39-UNC-39::GFP)* and RID phenotypes in *unc-39* mutants using RID fluorescent markers (*Pceh-10::GFP*) and RID cell fate markers (*Pkal-1-GFP, Pser-2-GFP, Pmod-1-GFP)*, images were captured using a 63x objective on a Zeiss Axioplan two connected to a Hamamatsu ORCA-ER digital camera and processed using Improvision Open Lab software. Images were processed using minimal deconvolution levels to remove background fluorescence. Confocal images of transgenic strains carrying either *Pflp-14-GFP*, *Pins17-GFP*, *unc-3fosmid::SL2::GFP*, and *unc-39fosmid::GFP* were acquired on a Nikon Eclipse 90i confocal microscope. Confocal image processing was conducted using Adobe Photoshop. The primer pair to generate a 4.3 kb *Pflp-14* fragment are tactgtcgaccgacaaacacccaaatatcc (forward, SalI) and aactggatcctccttcggattgtgtggag (reverse, BamHI).

Larval cell extraction and cell sorting {#s4-11}
---------------------------------------

Briefly, synchronized animals were pelleted and thoroughly washed with M9 Buffer to remove bacterial contamination. Prior to extraction, an aliquot of sample was flash-frozen in liquid nitrogen to be used as the All Cells reference sample for subsequent transcriptome analysis. To the remaining sample, freshly thawed SDS-DTT solution (0.25% SDS, 200 mM DTT, 20 mM HEPES, 3% sucrose pH = 7.5--8.0), which softens the cuticle, was added for no longer than 4 min (or until majority of animals started twitching, but did not become completely rod-like or rigid). Post-incubation with SDS-DTT, the sample was neutralized and washed 5x times with 1x Egg Buffer. To break apart animals, Pronase solution (15 mg/mL) was added, and the sample was pipetted \~40x for 30 min. After several washes, cells were resuspended in 1x Egg buffer. Propidium iodide (1 μg/mL) was added prior to cell sorting to identify damaged cells.

GFP+ cells from L2 worms were sorted onto Trizol-LS (Invitrogen) using a BD FACSAria with a 70 micron nozzle (BD Biosciences) operated at the University of Toronto Flow Cytometry Facility. Profiles of GFP+ strains were compared to an N2 standard to identify and exclude autofluorescent cells. For each independent replicate, 20,000--50,000 events, most likely representing cells, were FACS-isolated from each strain. Three and four biological replicates with corresponding All Cells reference samples were collected for the *hpIs202* control and *the unc-39 (hp701); hpIs202* strains, respectively.

RNA-sequencing preparation and analysis {#s4-12}
---------------------------------------

### RNA extraction {#s4-12-1}

For the all cells reference samples, flash-frozen pellets were pulverized using a mortar and pestle and dissolved in Trizol-LS (Invitrogen). RNA was extracted from these pulverized worm pellets (All and from sorted cells collected directly in Trizol-LS (GFP+ cells sample). DNA contamination was removed using the Zymo DNA-free RNA Kit (Zymo Research, Irving, CA) according to manufacturer's instructions.

### Library preparation and RNA-sequencing {#s4-12-2}

RNA sample concentration and quality were determined using an Agilent Bioanalyzer at The Centre for Applied Genomics (SickKids Hospital, Toronto, ON, Canada). RNA Integrity Numbers (RIN) scores of seven and above were used for subsequent RNA-sequencing analysis. RNA concentration was also verified using the Quibit RNA HS Kit (Thermo Fisher Scientific).

5 ng of RNA was used as starting material for cDNA library preparation. cDNA was synthesized from RNA using the SMARTer Ultra Low Input RNA Kit for Sequencing (Clontech) and cDNA libraries prepared using the Low Input DNA Library Prep Kit (Clontech) according to manufacturer's instructions. RNA-sequencing was performed on an Illumina Hiseq 2000 according to standard protocols, generating 100 base paired-end reads.

### Bioinformatics analysis {#s4-12-3}

Sequencing reads were mapped to the *C. elegans genome* (WS235) using RNA STAR under default settings ([@bib24]). Using these conditions on RNA STAR, 75--80% of reads aligned to a unique transcript. Gene expression quantification and differential expression were analyzed using HTSeq ([@bib4]) and DESeq ([@bib3]), respectively, under default settings.

Using DESeq, we identified differentially expressed transcripts between GFP+ cells and All Cells reference samples in the *hpIs202* and *unc-39(hp701);hpIs202* datasets. For *hpIs202* and *unc-39(hp701);hpIs202* datasets, transcripts were considered significantly enriched in GFP+ cells over sample matched All Cells by applying the following criteria or filters: (1) Differentially expressed transcripts with False Discovery Rate (FDR) adjusted p values\<0.05, and, (2) Transcripts where the ratio of log2 transformed Mean Counts from GFP+ samples to log2 transformed Mean Counts from All Cells samples was greater than 1 (Mean GFP+ Counts / Mean All Cells Counts \>1). Final datasets resulted from analyses of \>3 experimental replica from All cells and GFP+ samples for wild-type and *unc-39* mutant strains.

### Validation of the datasets {#s4-12-4}

Our final datasets were validated using \>3 replicates of the wild-type samples. We assessed its quality by two criteria: first, the identification of transcripts known to be expressed in RID, ALA, AIY, or CAN ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}; Positive Controls). We detected significant enrichment for transcripts reported to be expressed by either all GFP+ cells ([@bib91]), or a subset of GFP+ cells, e.g. in AIY (*ttx-3*, *hen-1*, *glc-3*, *pdfr-1*) ([@bib28]; [@bib46]; [@bib103]), and in RID (*lim-4*, *snf-11, zig-5, ser-2* and *kal-1*) ([@bib13]; [@bib70]; [@bib95]); Second, the absence of transcripts from non-neuronal tissues, such as muscles (*myo-2*, *myo-3)* or neuronal subtypes not included in GFP+ Cells - the glutamatergic (*eat-4*) and GABAergic (*unc-25*) neurons ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}; Negative Controls). Lastly, this study validated the presence of FLP-14 and INS-17 in RID ([Table 1](#tbl1){ref-type="table"}) by reporter analyses ([Figure 3](#fig3){ref-type="fig"}) and the functional relevance of FLP-14 ([Figure 6](#fig6){ref-type="fig"}).

Locomotion behavior analysis {#s4-13}
----------------------------

### Behavior acquisition and tracking {#s4-13-1}

When transferred to a new, thinly seeded plate, *C. elegans* typically spend most of the time moving forward, with brief interruptions of backward movement. As previously described with some modifications ([@bib32]), 35 mm Nematode Growth Media (NGM) plates with limited food (lightly seeded OP50 bacteria) were used for automated tracking and behavioral analyses. Using this method, we quantified the percentage of time animals spent moving forward, backward, and pausing. We also quantified initiation frequency, duration, and velocity of larval stage 4 (L4) animals. For RID-ablated animals, controls were mock-ablated animals carrying the same GFP reporter. For *unc-39, flp-14*, *ins-17*, and *npr-4 npr-11* genetic mutants, controls were N2 animals.

Prior to recording, animals were placed in the center of a 50 mm lightly seeded NGM plate and allowed to habituate for 5 min prior to recording. Behavior was recorded for 3 min under a 40x objective using a 20Zeiss Axioskop 2 Plus equipped with an ASI MS-40000 motorized stage and a CCD camera (Hamamatsu Orca-R2).

Tracking and analysis were performed using Micromanager and ImageJ software plugins developed in-house (courtesy of Dr. Taizo Kawano). Image sequences were sampled at 100-msec exposure (10 frames per second). The directionality of movement (forward vs. backward) was determined by first identifying the anterior-posterior axis or the 'head\' and \'tail' points, which were manually defined at the first two frames and verified throughout the recording. To calculate directionality of movement, the displacement of the midline point in relation to the head and tail for each worm was determined based on its position in the field-of-view and the stage coordinates. Image sequences where animals touched the edge of the recording field or crossed over on themselves were not processed.

### Quantification and data analyses {#s4-13-2}

Analyses of the output data were carried out using an R-based code developed in-house (courtesy of Dr. Michelle Po). The following parameters were quantified by the program: (1) Initiation (defined as the frequency of directional change for each animal); (2) Duration (defined as the time spent moving in the same direction for \>3 frames or 300 msec, calculated for each bout of forward or reversal initiation); (3) Velocity (defined by the speed, displacement of animal divided by the \# of frames, and directionality of the animal). Frequency of initiations, durations, and velocities were calculated for forward and reversal locomotion separately.

Calcium imaging and data analysis {#s4-14}
---------------------------------

Regions of interest (ROIs) containing the RID neuron was defined using a MATLAB script developed in-house. GCaMP and RFP fluorescence intensities from RID were then measured. To analyze overall RID activity, the ratio of GCaMP to RFP was calculated in order to control for possible motion artifacts detected. The velocity of each time point was measured using an Image J plug-in developed in-house ([@bib32]; [@bib54]). The rate for Acceleration during each transition from backward to forward locomotion was calculated by subtracting the lowest velocity point during backward locomotion from the highest velocity point during forward locomotion, and normalizing it to the number of frames in-between these two points (Velocity~peak~ -- Velocity~trough~ / \# of Frames). The rate of Deceleration during transitions from forward to backward locomotion was calculated similarly (Velocity~trough~ -- Velocity~peak~ / \# of Frames). Rise and decay in calcium transients during transitions from backward to forward locomotion and vice versa, respectively, were calculated using the linear slope. Cross-correlation analyses were performed between rate of acceleration and calcium rise, as well as deceleration and calcium decay.

Optogenetic stimulation and data analyses {#s4-15}
-----------------------------------------

To restrict expression of the Chrimson protein to RID, we drove the expression of a Chrimson::GFP:ZF construct by *Pceh-10*, in a subset of neurons (RID, ALA, AIY, and CAN), and the expression of ZIF-1::SL2::GFP by *Pgpa-14*, *Pttx-3*, and *Parr-1*, which overlap with *Pceh-10* for ALA, AIY, and CAN, respectively. ZIF-1 targets chrimson::GFP::ZF for degradation. GFP and RFP were used to confirm the specificity of expression pattern of these constructions in targeted neurons.

We first generated an integrated transgene *hpIs626* from an Ex array made from co-injected *Pceh-10-chrimson::GFP::ZF*, *Pgpa-14-ZIF::SL2::RFP*, *Pttx-3-ZIF::SL2::RFP* and the lin-15 co-injection marker. This transgene exhibits restricted chrimson::GFP expression in RID and CAN. *Parr-1-ZIF-1::SL2-RPF* was then injected in *hpIs626;*; \~10% of the double transgenic animals that carries the Ex array (*hpIs626;hpEx3808*) exhibited RID-specific chrimson::GFP expression. These array were then crossed into *unc-39*, *flp-14,* and *npr-4 npr-11* backgrounds.

For optogenetics experiments, we first picked late larvae to young adult transgenic animals by selecting for those with RID-specific GFP expression onto the OP-50 retinal plates under the dissecting fluorescent microscope. After 24 hr incubation, each animal was individually recorded using the COLBERT stimulation system (see below). After recording, each animal was mounted on slides to be examined for GFP signals; data collected from animals that exhibited residual GFP signals in CAN were discarded.

To make OP50-retinal plates, we seeded each 60 mm NGM plate with a mixture of 250 μL OP50 in LB with 1 μL of 100 mM retinal in ethanol. Animals were then individually washed in the NGM buffer before allowed to navigate on the surface of a 100 mm NGM plate without food. We used the Colbert system to stimulate Chrimson with a Diode red laser (MRL-III-635, 635 nm wavelength, 200 mW maximum power, CNI Laser) and carry out dark-field imaging using infrared light and a dark field condenser (Nikon) using a 10X Plano Apo objective (NA = 0.45). A motorized stage and custom real-time computer vision software kept the animal in the center of the field of view. The locomotion of each animal was recorded for 30 min or until it reached the edge of the plate. The laser was set at a 3 min on/3 min off cycle during the recording. Data was collected at 30 f/s and analyzed using a customized particle-tracking and shape analysis algorithms. Each trajectory was segmented into periods of forward movement (runs) separated by sharp orientations (turns). Turns were automatically flagged when the heading change of the center of the mass trajectory was \>60° over 1 s. To quantify the change of phase velocities before and after the laser was switched on ([Figure 6A,B](#fig6){ref-type="fig"}), we quantified velocity when the laser was on during a run with 10 s of forward movement before and after the switch for wild-type, *flp-14* and *npr-4 npr-11* animals, and 4 s before and 4 s after the switch for *unc-39* animals. To quantify the forward run length, all runs during the laser on phase and laser off phase were included.

Statistical analysis {#s4-16}
--------------------

For locomotion (\# of initiations, durations, velocities), statistical significance was determined using Mann-Whitney or Kruskal-Wallis tests for comparing two and more than two variables, respectively, and subjected to post-hoc analysis. For calcium imaging (correlations between acceleration/deceleration and rise/decay of calcium transients), Pearson tests were used to calculate correlation coefficients and statistical significance. For optogenetic stimulation and locomotion analyses, Wilcoxon matched-pairs signed rank test was used to compare the velocity difference during periods of Lights On and Off for the same strain. The Kruskal-Wallis Test with post-hoc test (Dunn's Multiple Comparison) was used to assess the significance of difference between groups. p\<0.05 were considered to be statically significant. All statistics were performed using Prism software (GraphPad).
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###### Table of control transcripts.
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###### Table of enriched transcripts in wild-type and unc-39 cells.
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###### 

A list of genetic mutant strains generated and/or used.

**DOI:** [http://dx.doi.org/10.7554/eLife.19887.027](10.7554/eLife.19887.027)

  **Gene**               **Allele**        **Strain**
  ---------------------- ----------------- ------------
  *unc-39 V*             *hp701*           ZM6539
  *unc-39 V*             *e257*            CB257
  *ced-3 IV*             *n717*            ZM6097
  *ced-4 III*            *n1162*           ZM6098
  *unc-3 X*              *xd86*            ZM9343
  *flp-14 III*           *gk1055*          ZM8969
  *ins-17 III*           *tm790*           ZM2860
  *Ins-17 flp-14 III*    *tm790 gk1055*    ZM9030
  *snf-11 V*             *ok156*           RM2710
  *flp-14III; snf-11V*   *gk1055; ok156*   ZM9215
  *npr-4 X*              *tm1782*          ZM9455
  *npr-11 X*             *ok594*           ZM9454
  *npr-4 npr-11 X*       *tm1782 ok594*    ZM9455

10.7554/eLife.19887.028

###### 

A list of constructs and transgenic strains generated and used (LIN-15 was used as an injection marker if not specified).

**DOI:** [http://dx.doi.org/10.7554/eLife.19887.028](10.7554/eLife.19887.028)

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Experiment                          Plasmid                                   Description (injection marker)      Background         Transgene          Strain
  ----------------------------------- ----------------------------------------- ----------------------------------- ------------------ ------------------ -----------
  ***RID Reporters***                 pJH2103                                   *Pceh-10::GFP*                      *lin-15(n765)*     *hpIs202*          ZM5488

  *hpIs201*                           ZM5489                                                                                                              

  pJH1647                             *Pceh-10::Cherry*                         *lin-15(n765)*                      *hpIs292*          ZM6905             

  pJH1647                             *Pceh-10::Cherry (pRF4)*                  *juIs1*                             *hpIs162*          ZM8000             

  pJH2160\                            *Pceh-10::IDA-1::Cherry*\                 *lin-15(n765)*                      *hpEx3669*         ZM8823             
  pJH2247                             *Pceh-10::ins-22::GFP*                                                                                              

  pJH2247\                            *Pceh-10::ins-22::GFP*\                   *lin-15(n765)*                      *hpEx3669*         ZM8823             
  pJH2160                             *Pceh-10::IDA-1::Cherry*                                                                                            

  Hobert lab                          *Pkal-1::GFP*                             *unknown*                           *otIs33*           OH904              

  Hobert lab                          *Pser-2::GFP*                             *unknown*                           *otIs107*          OH2246             

  pJH2715                             *Pmod-1::mito::GFP*                       *lin-15(n765)*                      *hpIs274*          ZM6658             

  Huang lab                           *unc-3 fosmid::SL2::GFP (sur-5::RFP)*     *unc-3(xd86); hpIs162*              *xdEx1091*         XD2319             

  ***unc-39 Related***                pJH2765                                   *Plim-4::lim-4::GFP*                *lin-15(n765)*     *hpEx3035*         ZM7100

  pJH2839                             *Punc-39::GFP*                            *lin-15(n765)*                      *hpIs328*          ZM7150             

  pJH2798                             *Genomic unc-39 minimal rescuing clone*   *unc-39(hp701);*                    *not maintained*   *not maintained*   

  pJH3138                             *unc-39fosmid::GFP (Pmyo-3::RFP)*         *unc-39(e257)*                      *hpEx3186*         ZM7572             

  pJH2811                             *Punc-39::UNC-39::GFP (RF4)*              *unc-39(hp701);\                    *hpEx3034*         ZM7482             
                                                                                hpIs292*                                                                  

  pJH2839                             *Punc-39::GFP*                            *lin-15(n765)*                      *hpIs328*          ZM7150             

  pJH3366                             *Punc-39::unc-3 cDNA (RF4)*               *unc-39(hp701);*\                   *hpEx3498*         ZM8312             
                                                                                *hpIs202*                                                                 

  pJH3084\                            *Punc-39::LIM-4 cDNA::GFP*\               *unc-39(hp701);*\                   *not maintained*   *not maintained*   
  pJH3366                             *Punc-39::UNC-3 cDNA*                     *hpIs292*                                                                 

  ***flp-14 Related***                pJH3884                                   *flp-14 genomic miniMos (Neo^R^)*   *N2 (wt)*          *hpSi38*           ZM9518

  *flp-14(gk1055)*                    *hpSi38*                                  ZM9474                                                                    

  *flp-14(gk1055);*\                  \                                         \                                                                         
  *unc-39(hp701)*                     *hpSi38*                                  ZM9468                                                                    

  *hpIs201*                           *hpSi38*                                  ZM9473                                                                    

  *flp-14(gk1055);*\                  \                                         \                                                                         
  *hpIs201*                           *hpSi38*                                  ZM9519                                                                    

  pJH2103                             *Pceh-10::GFP*                            *flp-14(gk1055)*                    *hpIs201*          ZM9502             

  ***flp-14 and ins-17 Reporters***   pJH3608                                   *Pflp-14::GFP*                      *lin-15(n765)*     *hpEx3695*         ZM8935

  Hutter lab                          *Pins-17::GFP (unc-119)*                  *unc-119(ed3)*                      *wwEx73*           HT1734             

  ***Calcium Imaging***               pJH3644                                   *Pflp-14::GCaMP6::Cherry*           *lin-15(n765)*     *hpIs587*          ZM9078

  *hpIs321*                           *hpIs587*                                 ZM9312                                                                    

  *juIs440*                           *hpIs587*                                 ZM9404                                                                    

  ***Optogenetic Stimulation***       pJH3790\                                  *Pceh10::Chrimson::GFP::ZF*\        *lin-15(n765)*     *hpIs626*          ZM9331\
                                      pJH3796\                                  *Pttx-3::ZIF-1::SL2::RFP*\                                                (RID/CAN)
                                      pJH3774                                   *Pgpa-14::ZIF-1::SL2::RFP*                                                

  pJH3835                             *Parr-1-ZIF-1::SL2::RFP*                  *hpIs626*                           *hpEx3808*         ZM9351\            
                                                                                                                                       (RID only)         

  *unc-39(hp701);*\                   *hpEx3808*                                ZM9472\                                                                   
  *hpIs626*                                                                     (RID only)                                                                

  *flp-14(gk1055);*\                  *hpEx3808*                                ZM9476\                                                                   
  *hpIs626*                                                                     (RID only)                                                                

  *npr-4(tm1782)*\                    *hpEx3808*                                ZM9529\                                                                   
  *npr-11(ok594);*\                                                             (RID only)                                                                
  *hpIs626*                                                                                                                                               
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------
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Decision letter
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,
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Neuroendocrine Modulation Sustains the *C. elegans* Forward Motor State\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Eve Marder as the Senior Editor and Reviewing Editor. The following individual involved in review of your submission has agreed to reveal his identity: Akinao Nose (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

In this manuscript the authors go to significant length to argue that a newly identified neuroendocrine neuron is important in behavior. All of the reviewers found the manuscript interesting, but have some specific issues that need addressing.

Essential revisions:

Most notably, please move [Figure 7](#fig7){ref-type="fig"} to the Results section. Also, please revise the manuscript, using the reviews as a guide, to distinguish clearly what you have done and what is a speculative conclusion. Speculations and a speculative cartoon model are fine for the Discussion as long as the reader is clearly told what are findings and what are speculations.

I am leaving portions of the initial reviews for your information because I don\'t think they are in disagreement and might be informative to you.

*Reviewer \#1:*

This manuscript takes the novel approach of identifying possible neuroendocrine cells by sTEM and determining their functions. The authors identify the RID neuron as a neuroendocrine cell because of its large number of dense core vesicles. In a screen for mutants that specifically disrupt RID differentiation, they identified the Six/SO homeodomain transcription factor UNC-39. Loss of unc-39 results in loss of several RID markers and its distinctive axonal morphology. Although the unc-39 results are solid, they were not well integrated into the overall theme of the paper (neuropeptide modulation of forward movement).

During forward movement, calcium levels in RID increased, whereas forward to reverse transitions caused a decrease in calcium levels, suggesting that RID is involved in forward movement. The calcium imaging was supported by behavioral work that showed that unc-39 mutants and RID-ablated animals had shorter forward runs and more turns than wild type, although unc-39 mutants had a more severe phenotype than the RID-ablated animals ([Figure 1A](#fig1){ref-type="fig"}), suggesting that unc-39 regulates other neurons that sustain forward movement. The authors followed up by showing that optogenetic stimulation of RID caused a sustained increase in forward velocity and runs.

The authors performed a subtractive transcriptome analysis to identify three candidate neuropeptide genes that are enriched in RID: flp-14, ins-17, and nlp-34. flp-14 mutants show a decreased average forward run duration, an increased number forward initiations, and an increased number of reversal initiations compared to wild type. However, as the authors note, the defects in flp-14 are not as severe as in unc-39 mutants and RID-ablated animals, suggesting that other peptides may act in concert with FLP-14 to modulate forward movement. In addition, the behavioral assays were highly variable (i.e., the SEMs are very large, suggesting a lot of variability in the behaviors). For instance, the wild-type values for average forward duration were significantly different in [Figures 5A\' and 5C\'](#fig5){ref-type="fig"}. This variability makes looking at defects in flp-14 mutants and its rescue difficult; for instance, 1) the average forward duration for flp-14 mutants looked significantly different from wild type in [Figure 5A\'](#fig5){ref-type="fig"}, but not really in [Figure 5C\'](#fig5){ref-type="fig"}; 2) the flp-14 mutants were not rescued with a copy of the flp-14 transgene for average forward duration to levels seen in wild type or even the flp-14 transgenics alone ([Figure 5B\'](#fig5){ref-type="fig"}); and 3) the flp-14 mutants did not look significantly different from the flp-14 transgenic line ([Figure 5C\'](#fig5){ref-type="fig"}). The only consistent defect seen with the flp-14 mutants was the decrease in the number of forward initiations. The authors should re-word some of their statements.

The authors indicate that ins-17 mutants acted similarly as wild type and the double mutants acted similar to the flp-14 mutants alone. However, flp-14 ins-17 double mutants showed more severe phenotypes than flp-14 mutants alone ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}), contrary to what the authors indicate, suggesting that INS-17 peptides might also be contributing to forward movement. Their statement should be re-worded.

Analysis of the possible FLP-14 receptors was not very informative. Double knockout of the possible receptors, NPR-4 and NPR-11, showed phenotypes that were not significantly different than wild type, but showed the same general trend as flp-14 mutants. Despite this negative result, [Figure 7](#fig7){ref-type="fig"} should be included in the text rather than in the Discussion.

The paper lacks a model of how RID inputs into the motor circuit to sustain forward motion. RID synapses onto hypodermal cells, DD neurons, and muscle, but could also act humorally. Do the authors hypothesize that the effect of FLP-14 peptides released from RID is on DD neurons, muscle, or other targets? In Ascaris, application of FLP-14 on muscle causes relaxation followed by rhythmic contractions or sustained contractions (depending on which paper one reads). The authors should have a model for the neuromodulation.

*Reviewer \#2:*

1\) Specificity of the activation experiments with Chrimson. Please explain more in detail how the authors restricted the expression of Chrimson to RID neurons using the ubiquitin ligase system. Since the specificity of Chrimson expression is critical for the interpretation of the results, inclusion of a picture showing the specific expression as a supplementary figure would be desirable. I also wonder how one should interpret the results of the optogenetic activation in unc-39 mutants. Is the reversion of the phenotype due to lack of Chrimson expression in RID or defective function of the neuron?￼￼

2\) It is not clear how RID regulates forward locomotion. I would expect more through discussion on putative target cells of RID in relation to known locomotory circuits. An obvious candidate would be DD MNs whose terminals reside in the immediate neighbor of RID varicosities. What happens to forward locomotion when DD MNs are inhibited or activated? If feasible, the authors may also examine if the activity manipulation of RID or application of FLP-14 affects the level of Ca^2+^ or other signaling molecules (e.g., cAMP) in DDs.

*Reviewer \#3:*

1\) There seems to be a caveat implied by [Figure 6](#fig6){ref-type="fig"} that should be discussed. The speed of unstimulated flp-14 mutants was significantly higher than that of wild-type while the stimulated speeds of the two strains were much more similar. Therefore, a possible (plausible?) interpretation of the difference in fold change is a ceiling effect. The animals, on average, didn\'t move faster than \~0.55 body-lengths per sec such that the unstimulated mutants didn\'t have as much capacity for speedup as wild-type. The data in panel C possibly suffers from a similar (not unrelated) issue: T_off for the mutants is higher than wild-type.

If so, the optogenetic assay does not strongly support the conclusions of the manuscript although it doesn\'t contradict them either. It is perfectly reasonable for a particular assay of a complex phenomenon to fall short of providing conclusive evidence. It is even useful to present such results by way of transparency and completeness. Thus, the data is useful and should be presented in the main text without detracting from the interest of the manuscript or the validity of the conclusions.

If I am mistaken, perhaps the caveat should be briefly mentioned and refuted for the sake of clarity. Otherwise, the caveat should be discussed and the conclusion of the relevant Results section should be revised to state that the optogenetic assays were consistent with the overall theme of the work but in and of themselves inconclusive.

2\) [Figure 7](#fig7){ref-type="fig"} depicts a negative result, suggesting that the predicted receptors of FLP-14 do not directly affect forward locomotion (either because the prediction is wrong or because their interaction with multiple ligands is more complex). I think that such data does belong in a Results section. It is of practical importance to *C. elegans* researchers and of conceptual importance to any researcher that felt the need to tuck away a valid result in the name of a \'cleaner\', more linear story.

10.7554/eLife.19887.030

Author response

Essential revisions:

*Most notably, please move [Figure 7](#fig7){ref-type="fig"} to the Results section. Also, please revise the manuscript, using the reviews as a guide, to distinguish clearly what you have done and what is a speculative conclusion. Speculations and a speculative cartoon model are fine for the Discussion as long as the reader is clearly told what are findings and what are speculations.*

*I am leaving portions of the initial reviews for your information because I don\'t think they are in disagreement and might be informative to you.*

**Response**: Thank you. We gladly moved the figure and related texts to the Results (see [Figure 8](#fig8){ref-type="fig"} in Resubmission; [Figure 7](#fig7){ref-type="fig"} in previous submission). We clarified in figure legends that the upper panel in the model sketch in [Figure 8E](#fig8){ref-type="fig"} ([Figure 6D](#fig6){ref-type="fig"} in previous submission) summarizes our findings on RID, whereas the lower panel represents the unknown downstream signaling from RID. We do not yet know how RID integrates in the forward circuit, a point that we expanded in Discussion. We feel more comfortable showing our conclusions with minimal speculation, and hope that this is acceptable. We appreciate comments from all reviewers and summarize below our responses and revisions that we made in the re-submitted manuscript.

Reviewer \#1:

*This manuscript takes the novel approach of identifying possible neuroendocrine cells by sTEM and determining their functions. The authors identify the RID neuron as a neuroendocrine cell because of its large number of dense core vesicles. In a screen for mutants that specifically disrupt RID differentiation, they identified the Six/SO homeodomain transcription factor UNC-39. Loss of unc-39 results in loss of several RID markers and its distinctive axonal morphology. Although the unc-39 results are solid, they were not well integrated into the overall theme of the paper (neuropeptide modulation of forward movement).*

**Response:** Thank you. The *unc-39* work, including the embryonic lineage analyses that denote its deficiency of RID neurogenesis, its EM analyses, its motor behavioral deficit, and RNA profiling of *unc-39* neurons, could indeed be a stand-alone study. The focus of such a 'paper' would have been UNC-39's requirement for RID's development. However, the focus of our paper, representing the main interest of my group, is the RID neuron and its role in the motor circuit.

In our study, UNC-39 is an essential tool for three key aspects of RID: 1) RID's identity as a peptidergic neuron. In *unc-39* mutants, there is failure of RID neurogenesis. The absence of a neurite with neuroendocrine properties in the dorsal nerve cord of *unc-39* mutants confirms that the one that we observed in the wild-type dorsal nerve cord was RID. 2) RID promotes forward run. The motor behaviors of *unc-39* mutant reiterate those that we observed for RID-ablated animals; the absence of a behavioral response to optogenetic stimulation of the RID neuron serves as a control and confirms the cellular origin of the effect was RID. 3) FLP-14 and other neuropeptides are expressed by RID. Since we do not have a RID-specific promoter, we took advantage of *unc-39*'s absence of RID to perform subtractive RNA profiling to search for RID-enriched transcripts. Indeed UNC-39 transcriptional targets are likely present in this list, but this was not our focus. The sole reason to provide those data was to be useful to those who are interested in pursuing UNC-39's targets, and we are confident of the reproducibility and quality of these datasets.

This is why our *unc-39*-relatedresult sections focused on evidence for RID's absence in *unc-39* mutants; the rest of the *unc-39* work was distributed in our Results sections where they are integrated as controls. In the Discussion, we now further highlight the relevance of the *unc-39* data to the overall theme of the paper: the absence of RID in *unc-39* mutants has provided our work a genetic tool to investigate the property, function, and molecular mechanisms of RID. We further refer to published work on *Drosophila* Six; together they suggest that UNC-39/Six/SO transcription factors may have a shared role in endocrine development.

*During forward movement, calcium levels in RID increased, whereas forward to reverse transitions caused a decrease in calcium levels, suggesting that RID is involved in forward movement. The calcium imaging was supported by behavioral work that showed that unc-39 mutants and RID-ablated animals had shorter forward runs and more turns than wild type, although unc-39 mutants had a more severe phenotype than the RID-ablated animals ([Figure 1A](#fig1){ref-type="fig"}), suggesting that unc-39 regulates other neurons that sustain forward movement. The authors followed up by showing that optogenetic stimulation of RID caused a sustained increase in forward velocity and runs.*

*The authors performed a subtractive transcriptome analysis to identify three candidate neuropeptide genes that are enriched in RID: flp-14, ins-17, and nlp-34. flp-14 mutants show a decreased average forward run duration, an increased number forward initiations, and an increased number of reversal initiations compared to wild type. However, as the authors note, the defects in flp-14 are not as severe as in unc-39 mutants and RID-ablated animals, suggesting that other peptides may act in concert with FLP-14 to modulate forward movement.*

**Response:** These are our conclusions. We agree that behavioral differences summarized by bar graphs may not be sufficiently informative for readers without direct experience performing *C. elegans* motor behavior assays. To place these quantitative analyses in a more visual context, we now provide supplemental figures where we show the raw data that were used for quantification. They allow a qualitative, but very intuitive view of the data variability of the same genotype, and the degree of difference across groups. It should be evident from these raw data that the motor phenotypes of *unc-39* and RID-ablated animals were quite similar, and *flp-14*'s defect was of the same trend but less severe compared to the *unc-39* or RID-ablated animals. These points have been articulated in Results and Discussion.

*In addition, the behavioral assays were highly variable (i.e., the SEMs are very large, suggesting a lot of variability in the behaviors). For instance, the wild-type values for average forward duration were significantly different in [Figures 5A\' and 5C\'](#fig5){ref-type="fig"}. This variability makes looking at defects in flp-14 mutants and its rescue difficult; for instance, 1) the average forward duration for flp-14 mutants looked significantly different from wild type in [Figure 5A\'](#fig5){ref-type="fig"}, but not really in [Figure 5C\'](#fig5){ref-type="fig"}; 2) the flp-14 mutants were not rescued with a copy of the flp-14 transgene for average forward duration to levels seen in wild type or even the flp-14 transgenics alone ([Figure 5B\'](#fig5){ref-type="fig"}); and 3) the flp-14 mutants did not look significantly different from the flp-14 transgenic line ([Figure 5C\'](#fig5){ref-type="fig"}). The only consistent defect seen with the flp-14 mutants was the decrease in the number of forward initiations. The authors should re-word some of their statements.*

**Response:** We appreciate the reviewer's keen observations on the behavioral defects of *flp-14* mutants.

a\) We now provide raw behavioral recording data ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} and [Figure 6---figure supplements 1](#fig6s1){ref-type="fig"} and [2](#fig6s2){ref-type="fig"}) so readers can view directly the variability between strains;

b\) Regarding the concern about the variability, and *flp-14* rescue in former [Figure 5B](#fig5){ref-type="fig"} was not back to the wild-type level in another panel (former [Figure 5A](#fig5){ref-type="fig"}), we need to clarify several points. First, 'wild-type' animals in the original 5A and 5B/C refer to animals of different genetic backgrounds, because they served as the wild-type control for each experimental group. In [Figure 5A](#fig5){ref-type="fig"}, 'wild-type' was N2, a non-transgenic strain where *flp-14* and *unc-39* mutants were derived from. In [Figure 5B](#fig5){ref-type="fig"}, 'wild-type' was *Si(FLP-14)*, a transgenic line with a single copy integrant of the FLP-14 rescuing construct. In [Figure 5C](#fig5){ref-type="fig"}, 'wild-type' was *Si(FLP-14);hpIs202* -- *hpIs202* being a GFP marker for visualizing RID. These controls were not to be compared with each other. The genotype information is provided in figure legends. Second, even for strains of the identical genetic background, the absolute value of the motor behavioral index would exhibit variability when they are assayed on different days. In our behavioral assays, we only compare values of animals assayed on the same day and on the same plate, as we explained in the Materials and methods and Appendix 1. The variability we observed is standard for these motor behavioral assays that were performed by our group, so we are confident with conclusions drawn from these data.

c\) Regarding the concern that *Si(FLP-14)* did not rescue *flp-14* back to *Si(FLP-14).* There was indeed one motor index between *flp-14;Si(FLP-14)* and *Si(FLP-14)* that showed really small, but statistically significant difference. An exogenous or even an overexpression of neuropeptides could easily generate effects on motor behaviors, and it was difficult to assert cellular origin of secreted molecules by standard transgenic rescue experiments. We generated a single copy insert of *flp-14* construct *Si(FLP-14)* under a portion of its own genomic regulatory elements to avoid these caveats as much as possible, but it is quite possible that *flp-14;Si(FLP-14) did not behave identical to Si(FLP-14)*. With the raw data, the rescuing effect should be quite obvious. The key point of this experiment was to ablate the RID neurons in the *Si(FLP-4)* background to determine if its rescuing effect was reversed.

We have reworded the statement to reflect these points.

*The authors indicate that ins-17 mutants acted similarly as wild typ￼e and the double mutants acted similar to the flp-14 mutants alone. However, flp-14 ins-17 double mutants showed more severe phenotypes than flp-14 mutants alone ([Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}), contrary to what the authors indicate, suggesting that INS-17 peptides might also be contributing to forward movement. Their statement should be re-worded.*

**Response:** In the original [Figure 5---figure supplement 1D](#fig5s1){ref-type="fig"}, *flp-14 ins-17* double mutants were compared against wild-type and *ins-17*. During revision, we realized that we had forgotten to replace an older version of the figure, resulting in the absence of the *flp-14* panel in the previous submission altogether.

We have replaced it with the proper panel. We moved these results to the main figure and provided raw behavior data as a supplemental figure. As shown in [Figure 5B](#fig5){ref-type="fig"} and supplemental raw data ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}) in the resubmission, *ins-17* did not significantly enhance *flp-14*'s motor defects. Double mutants did exhibit a trend of slightly decreased reversal duration, forward, and reversal velocity when compared to *flp-14* alone, but the change is so small, excluding *ins-17* being a main regulator of motor behaviors. We have reworded the text to state that *ins-17* is not a main contributor. We thank the reviewer for bringing it to our attention.

*Analysis of the possible FLP-14 receptors was not very informative. Double knockout of the possible receptors, NPR-4 and NPR-11, showed phenotypes that were not significantly different than wild type, but showed the same general trend as flp-14 mutants. Despite this negative result, [Figure 7](#fig7){ref-type="fig"} should be included in the text rather than in the Discussion.*

**Response:** Agree. We have incorporated this data into the Results section (see [Figure 8](#fig8){ref-type="fig"} in resubmission).

*The paper lacks a model of how RID inputs into the motor circuit to sustain forward motion. RID synapses onto hypodermal cells, DD neurons, and muscle, but could also act humorally. Do the authors hypothesize that the effect of FLP-14 peptides released from RID is on DD neurons, muscle, or other targets? In Ascaris, application of FLP-14 on muscle causes relaxation followed by rhythmic contractions or sustained contractions (depending on which paper one reads). The authors should have a model for the neuromodulation.*

**Response:** Indeed. We do not have any positive data or conclusions on RID's downstream targets. As we previously discussed, the *Ascaris* electrophysiology work alluded to a possibility of muscles and forward driving motor neurons being the potential targets. This notion would contradict the candidate neurons based on expression pattern of the predicted FLP-14 receptors (interneurons). Because of our negative data on these receptor mutants, we favor clues from the *Ascaris* work.

To make a speculative model that does not mislead other researchers, we placed question marks on these candidate targets in the model sketch. In the Discussion, we further emphasize the necessity to identify FLP-14's physiological receptors in order to determine RID target cells. Although DD and hypodermis were the postsynaptic partner of RID in the adult wiring diagram, this was based on their anatomic apposition to the few active zones observed along the RID axon. This approach may have its limitations because \~90% of RID axonal boutons lack active zones; for the \~10% with active zones, we never observed docked clear or dense core vesicles.

Reviewer \#2:

*1) Specificity of the activation experiments with Chrimson. Please explain more in detail how the authors restricted the expression of Chrimson to RID neurons using the ubiquitin ligase system. Since the specificity of Chrimson expression is critical for the interpretation of the results, inclusion of a picture showing the specific expression as a supplementary figure would be desirable.*

**Response:** We added the description in the Results, and expanded the methods (see Appendix 1) on obtaining these strains. A supplementary figure containing the requested image has been added ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}).

*I also wonder how one should interpret the results of the optogenetic activation in unc-39 mutants. Is the reversion of the phenotype due to lack of Chrimson expression in RID or defective function of the neuron?*

**Response:** Because RID neurogenesis fails in *unc-39* mutants, the lack of Chrimson expression in RID and subsequently the absence of an activation response to light stimulation serves as a negative control to ensure that the effect of optogenetic light stimulation was dependent on the presence of the RID.

*2) It is not clear how RID regulates forward locomotion. I would expect more through discussion on putative target cells of RID in relation to known locomotory circuits. An obvious candidate would be DD MNs whose terminals reside in the immediate neighbor of RID varicosities. What happens to forward locomotion when DD MNs are inhibited or activated? If feasible, the authors may also examine if the activity manipulation of RID or application of FLP-14 affects the level of Ca^2+^ or other signaling molecules (e.g., cAMP) in DDs.*

**Response:** We thank the reviewer for this suggestion. We do not understand how RID regulates forward locomotion in the context of other circuit components. We provide more background and expand Discussion in the revised manuscript. DD could be a candidate due to its proximity, but other motor neuron neurites are also fairly close. A main issue is that the post-synaptic partner of peptidergic neurons could not be reliably predicted by anatomic apposition. We also suspect that the predicted FLP-14 receptors are incorrect: we did not find any supportive experimental evidence for the predicted FLP-14 receptor mutants ([Figure 8](#fig8){ref-type="fig"} in Resubmission). The proposed experiments will be informative, but we feel that it is only the starting point for deciphering the RID circuit. It should be the focus of future investigation.

Reviewer \#3:

*1) There seems to be a caveat implied by [Figure 6](#fig6){ref-type="fig"} that should be discussed. The speed of unstimulated flp-14 mutants was significantly higher than that of wild-type while the stimulated speeds of the two strains were much more similar. Therefore, a possible (plausible?) interpretation of the difference in fold change is a ceiling effect. The animals, on average, didn\'t move faster than \~0.55 body-lengths per sec such that the unstimulated mutants didn\'t have as much capacity for speedup as wild-type. The data in panel C possibly suffers from a similar (not unrelated) issue: T_off for the mutants is higher than wild-type.*

*If so, the optogenetic assay does not strongly support the conclusions of the manuscript although it doesn\'t contradict them either. It is perfectly reasonable for a particular assay of a complex phenomenon to fall short of providing conclusive evidence. It is even useful to present such results by way of transparency and completeness. Thus, the data is useful and should be presented in the main text without detracting from the interest of the manuscript or the validity of the conclusions.*

*If I am mistaken, perhaps the caveat should be briefly mentioned and refuted for the sake of clarity. Otherwise, the caveat should be discussed and the conclusion of the relevant Results section should be revised to state that the optogenetic assays were consistent with the overall theme of the work but in and of themselves inconclusive.*

**Response:** We thank the reviewer for bringing this observation to our attention. We have re-examined all data to see if there is a general trend of higher activity in *flp-14* mutants before stimulation when compared to other animals, and whether the post-stimulation velocity represented the highest velocity in these recordings. This was not the case, and we take this opportunity to elaborate on these experiments and analyses done.

In [Figure 7](#fig7){ref-type="fig"} (previously [Figure 6](#fig6){ref-type="fig"}), we had purposely avoided comparing the mean velocity across strains because it would not be accurate. For a velocity comparison between wild-type and *flp-14*, we refer to [Figure 5A](#fig5){ref-type="fig"}. These assays, where we compared animals of matched age on the same day and on the same plate, provide the accurate assessment. As shown in Results, there was no substantial difference between the mean spontaneous forward velocity between wild-type and *flp-14*.

To reiterate the methodology used for the optogenetic stimulation experiment (we described it in detail in Appendix 1, shortened here), we recorded one animal at a time, with a 3 minute light on/3 minute light off protocol for 30 minutes, or until we lost track of the animal before 30 minutes. Stimulation on and off events were pooled (N) from recordings of the same genotype, and we compared the motor behaviors with and without stimulation within the same recording using two indexes: a) The mean duration of all forward run events during the ON and OFF periods ([Figure 7A](#fig7){ref-type="fig"}; previously [Figure 6C](#fig6){ref-type="fig"}). b) The velocity before and after the simulation ([Figure 7B, C](#fig7){ref-type="fig"}; previously [Figures 6A, B](#fig6){ref-type="fig"}). The index from 7A is directly relevant to our conclusion -- RID activation positively correlates with prolonged forward run. We were glad we also saw a trend of increased velocity after RID stimulation, which supported, but was not definitive for our conclusion.

The reviewers may have noticed that the N number for quantified velocity change before and after stimulation ([Figure 7B, C](#fig7){ref-type="fig"}) is much smaller than the N number for the distribution graph of forward duration for ON and OFF period ([Figure 7A](#fig7){ref-type="fig"}). This was because the motor state of the animal, when the light was on, was random. There was a concern with a timing effort (e.g. the animal was at a low or high velocity forward state when the stimulation was turned on), or, false negative effect (e.g. we hit the animal when it was reversing). Hence we selected for stimulation events that happened within a forward run, with at least 4 seconds before and after the stimulation. The previous choice of 4s was set by the motor defects of *unc-39* mutants: these animals almost exclusively exhibited short runs; if we chose a longer time, N from the *unc-39* dataset would be too small.

These experiments were very labor-intensive. Because only 10% of our transgenic animals exhibited removal of Chrimson from non-RID neurons (see Appendix 1 for details), we picked as many candidate RID-specific old larvae to young adult animals as possible from three genotypes under low magnification fluorescent microscopes, cultured them on retinal plates, and recorded all animals on the following day. This amounted to 12-14hr recording, for three genotypes of \~6\~10 animals/genotype). After recording, we mounted each animal to examine with a high magnification microscope, and discarded data from animals that showed residual chrimson signals in neurons other than RID. Three independent repeats were performed. The scarcity of samples prevented us from using animals at the identical developmental stage, and we had to pool recording data obtained on different dates. Together with the small number of Ns for velocity comparison, we felt that we should only use these datasets to compare the motor behavior within the same recording, hence the normalized difference at the ON and OFF period. In fact, we knew that the absolute velocity value in these panels did not represent the spontaneous velocity as observed under culturing conditions -- *unc-39* exhibited a non-ambiguous drastic reduction in velocity when compared to both wild-type and *flp-14* animals ([Figure 5](#fig5){ref-type="fig"} and videos), which was not reflected by the original [Figure 6A](#fig6){ref-type="fig"} ([Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}) at all.

In revision, we place the more relevant, run duration panel ahead of the velocity panel. We also present the velocity values using scatter plots for an easier comparison between individual pairs. Moreover, we have now examined and presented the mean velocity before and after stimulation for 10 seconds for wild-type, *flp-14* and *npr-4 npr-11* mutants (a more representative mean speed), while keeping *unc-39's* cut off to 4 seconds. These data led to the same conclusion ([Figure 7](#fig7){ref-type="fig"} and [Figure 8](#fig8){ref-type="fig"}).

*2) [Figure 7](#fig7){ref-type="fig"} depicts a negative result, suggesting that the predicted receptors of FLP-14 do not directly affect forward locomotion (either because the prediction is wrong or because their interaction with multiple ligands is more complex). I think that such data does belong in a Results section. It is of practical importance to C. elegans researchers and of conceptual importance to any researcher that felt the need to tuck away a valid result in the name of a \'cleaner\', more linear story.*

**Response:** Agreed. We moved [Figure 7](#fig7){ref-type="fig"} ([Figure 8](#fig8){ref-type="fig"} in the resubmission) to the main Results section.
